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I  
INTRODUCTION 
The quanclcatlve evaluation of vitamin A nutriture is 
not a straightforward process (I). This situation contrasts 
with that of some other vitamins, such as riboflavin, where 
blood concentrations or plasma levels of a vitamin dependent 
enzyme can be used as a reliable gauge of nutritional status 
(2). The difficulty in determining the nutritional status 
of vitamin A results from the Inherent way in which vitamin 
A is metabolized rather than from an inability to measure 
accurately its levels physically or chemically. A 
description of the way In which vitamin A is stored and 
metabolized will help to clarify this statement. 
In the gut, vitamin A esters are cleaved to retlnol, 
while carotenolds with vitamin A activity are cleaved to 
retinaldehyde and then reduced to retlnol (3,4). The 
retlnol from both sources Is reesterlfled, predominantly to 
the palmltate ester (5). These retlnyl esters are 
Incorporated Into chylomicrons and transported to the 
general circulation via the lymphatic system. Hydrolysis of 
most of the chyloolcron-bound triglycerides by lipoprotein 
lipase and the removal of free fatty acids leaves a 
chylomicron remnant containing the retlnyl esters, 
cholesteryl esters, phospholipids and protein. This remnant 
Is taken up by the hepatocytes (parenchymal cells) of the 
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liver (6,7). At Che site oE uptake, reCinyl esters appear 
to be hydrolyzed, reesterlfied and stored (6-9). 
The major sites of vitamin A storage appear to be the 
lipid droplets in the stellate cells and parenchymal cells 
o£ the liver (10). This storage occurs both in cases of 
normal vitamin A nutriture and under conditions of a large 
dietary excess of vitamin A (11,12). Under conditions of 
vitamin A deficiency, dietary retinol taken up by the liver 
is immediately mobilized from the hepatocyte into the 
circulation for transport to peripheral tissues (13). 
Vitamin A stored in the liver normally represents about 
90% of the vitamin A in the body, 95% of which is in the 
form of retinyl esters (13,14,15). Vitamin A is mobilized 
from the liver storage pool in the form of the free alcohol 
bound to a specific plasma protein, termed retinol-binding 
protein (RBP). This retinol-RBP complex is secreted 
specifically by hepatic parenchymal cells (16,17). The 
process whereby stored retinyl esters are transported 
between liver cell types and packaged for secretion has yet 
to be fully defined. 
The release of the retinol-RBP complex into the 
circulation is tightly regulated; as a consequence, the 
plasma vitamin A concentration is maintained at a constant 
or steady-state level. This homeostatically controlled 
steady-state level remains fairly constant over a wide range 
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of liver scores of vlcamin A (18). For this reason, the 
circulating plasma levels of vitamin A generally have little 
relationship to total body reserves of vitamin A. Not until 
the liver is almost entirely depleted of vitamin A do plasma 
levels of retlnol begin to reflect liver concentrations (1). 
Conversely, under conditions of hypervltaminosis A, retinyl 
esters bound to low-density lipoproteins are present in the 
plasma in significant amounts. 
A variety of factors control the plasma level of 
retlnol. Firstly, the release of the retinol-RBP complex 
appears to be controlled rather than the synthesis of RBP, 
since the synthesis rates of RBP and the RBP-specific mRNA 
are not affected by the vitamin A status of the animal 
(19-21). Steroid hormones appear to influence the 
homeostatic levels of plasma vitamin A. Plasma RBP levels, 
and therefore retlnol concentrations, are known to increase 
with increased levels of steroid sex-hormones as found In 
the natural cycles of females of several species. Including 
humans (22-26). This mechanism Is proposed to operate 
through Increased hepatic synthesis of RBP and subsequent 
mobilization (26). Estrogen-containing contraceptives have 
also been found to Increase circulating levels of RBP 
(26-29). Plasma RBP levels Increase at the time of puberty 
from the adolescent level, which is approximately 40% lower, 
to the adult level, indicating that some type of hormonal 
control is being exerted (30). Stress, on the other hand, 
appears to decrease plasma vitamin A levels (31). 
The second major factor known to influence the plasma 
retinol transport system is malnutrition. Protein-energy 
malnutrition (PEM) results in decreased plasma levels of RBP 
and vitamin A as a result of an insufficient supply of amino 
acids and energy for the synthesis and secretion of the 
retinol-RBP complex. In one study where children with 
classical kwashiorkor were treated with calories and 
protein, a significant increase In RBP, transthyretin (TTR), 
and serum retinol was reported even without supplemental 
vitamin A (32). This finding has been born out in several 
other studies as well (33-37). 
The third major factor influencing plasma vitamin A 
levels in both PEM and in normal individuals is the supply 
of dietary vitamin A. Inadequate Intakes of vitamin A 
usually accompany PEM (38). In cases of chronic dietary 
lack of vitamin A, RBP accumulates In the liver (39-41). 
This accumulation occurs because RBP synthesis continues in 
the absence of retinol, but the apo-RBP Is not secreted from 
the liver. This fact has been exploited as a possible means 
to measure total body stores of vitamin A, as will be 
discussed later. 
After excretion by the liver, the retlnol-RBP complex 
binds to circulating transthyretin (prealbumin) in a 
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one-to-one molar ratio (38). This complex is the actual 
carrier which delivers retinol to what appear to be specific 
cell surface receptors which recognize RBP (42,43). It has 
long been known that vitamin A is necessary for vision, 
reproduction, growth, the maintenance of differentiated 
epithelia, and mucus secretion. The mode of action of 
vitamin A in tissues, other than In the visual cycle of the 
eye, remains to be defined, however (44). 
Thus, separate regulatory mechanisms seem to exist for 
the control of RBP synthesis and for the secretion of the 
retinol-RBP complex from the liver (45,46). To control 
secretion, an extra-hepatic feedback mechanism may well 
txist, by which target tissues are able to communicate their 
vitamin A requirements and thus maintain a relatively 
constant level of plasma retinol-RBP (45-47). 
After delivery of the bound retinol to specific target 
tissues, the RBP is released as apo-RBP. This apo-RBP has a 
lower affinity for TTR and is thus cleared readily by the 
renal glomeruli (48). Apo-RBP is then reabsorbed in the 
renal tubule and catabolized by the kidney. 
From this brief review of vitamin A metabolism several 
facts relative to measuring body stores of vitamin A become 
apparent. 
a) The liver is the major storage site of retinol and 
retlnyl esters. Any analysis of total body stores which 
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does not reflect the liver stores does not give a true 
indication of body stores. 
b) Plasma levels of vitamin A remain relatively constant 
over a wide range of liver vitamin A concentrations. The 
exact nature of this control has not been fully delineated, 
although several factors have been shown to influence the 
plasma vitamin A levels. Because of this tight control, 
direct measurement of plasma retinol will not indicate true 
vitamin A nutriture. This is especially important when 
trying to detect those populations which are marginal or 
slightly deficient in vitamin A. 
c) In cases of dietary insufficiency of vitamin A, RBP 
concentrations increase in the liver. 
It is of interest at this point to review current 
approaches to evaluating vitamin A status. As one recent 
review has stated "vitamin A status is the sum product over 
time of the dynamic processes involving intake, storage, 
mobilization, utilization, and excretion" (I). A less 
comprehensive but more workable definition would be in terms 
of whether or not an individual is well-nourished with 
respect to vitamin A, i.e., whether enough vitamin A is 
supplied in the diet. The liver stores of vitamin A are 
probably the best reflector of vitamin A status in this 
sense. Methodologies for measuring liver biopsy samples for 
vitamin A have been developed (49). However, the liver is 
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not an organ which can be routinely biopsied in living 
peculations. Barring direct measurement of liver vitamin A 
concentrations, several methods have been developed for use 
in diagnosing deficiency and measuring vitamin A status. 
These methods would be grouped into dietary, physiological, 
clinical and biochemical assessment. 
Dietary assessment of vitamin A nutrlture Involves 
obtaining sufficient Information on the quantity and vitamin 
A content of the food Ingested over a significant period of 
time. The main dietary sources of preformed vitamin A. 
I.e., vitamin A alcohol and retlnyl esters, are animal 
tissues. Livers of mammals, fish and fowl are the richest 
sources, but the fleshy tissues also provide significant 
amounts of vitamin A (I). 
The other major sources of vitamin A in the diet are 
carotenoids which have vitamin A activity. It has been 
estimated that 50-60 carotenoids could have provitamin A 
activity. The ability to be converted to compounds with 
vitamin A-like structures and therefore activity depends 
upon their ability to be absorbed and chemically modified in 
vivo (50). The best known carotenold is all-trans 
beta-carotene. Beta-carotene, as previously mentioned, is 
cleaved in the gut to two molecules of retlnaldehyde, which 
is further reduced to retinol (51). The efficiency of 
conversion of ingested beta-carotene to vitamin A in vivo is 
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approximately 50%, based on biological activity experiments 
(52). The efficiency of conversion of other carotenolds to 
vitamin A is dependent on the position and degree of 
modification in the beta-lonone ring and the polyene side 
chain (53). 
Assessment o£ vitamin A status by dietary Intake 
requires I) determination of the content, both of preformed 
vitamin A and of provitamin A sources, In the diet and the 
quality and bioavailability of those vitamin A forms, 2) 
determination of the quantity of those sources and the 
frequency of their consumption, and 3) careful collection of 
these data over a period long enough to ensure that seasonal 
and other variations in diet are included. 
Physiological signs of vitamin A deficiency are 
Indicated by night blindness and an abnormal 
electroretinogram. These are effectively measured on adults 
in laboratory situations, but are unsatisfactory for 
children In rural village situations (54). 
Clinical signs of depleted vitamin A stores or impaired 
vitamin A transport are manifested most clearly in the eye. 
Xerophthalmia, which means dry eye (55), is a general term 
used to describe signs and symptoms of vitamin A deficiency 
in the eye. The World Health Organization has classified 
xerophthalmia by ocular signs into the following categories: 
night blindness (XN), conjunctival xerosis (XlA), Bitot's 
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spot (XlB), corneal xerosis (X2), corneal ulceration (X3A, 
X3B), corneal scar (XS) and xerophthalmia fundus (XF)(56). 
These clinical signs appear when vitamin A stores are at a 
critically low level. The mild signs often lack 
specificity, however, and the more severe ones are rare and 
fleeting. 
Other clinical signs might be a decreased appetite and 
growth rate, decreased resistance to Infection, disturbances 
of the reproduction system and impaired iron metabolism. 
Because these signs can occur as the result of other 
nutritional deficiencies and environmental factors as well 
as of vitamin A deficiency, they cannot therefore be taken 
as specific measures of vitamin A nutriture (I). 
The biochemical assessment of vitamin A status relates 
either directly or indirectly to the body reserves of 
vitamin A. Serum analysis of plasma vitamin A 
concentrations, except when very low or very high, has been 
shown repeatedly not to reflect liver vitamin A 
concentrations in vitamin A-sufficient humans and in 
animals, for the reasons previously described (57-63). 
Attempts to predict liver vitamin A reserves by a 
correlation between plasma vitamin A levels and log^g of 
liver vitamin A reserves are plagued by high standard 
deviations and a lack of correlation between plasma vitamin 
A levels and liver vitamin A concentrations in the 
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physiological range (18,64-66). 
Simple procedures Eor measuring circulating levels o£ 
RBP have been developed using immunodiffusion assays 
(67,68). The simple measurement of circulating RBP levels 
fails to distinguish between holo-RBP and apo-RBP, however. 
Although the relative amounts of apo-RBP are <5% in a well-
nourished individual, circulating apo-RBP levels may be 
30-401 of RBP normal values In vitamin A deficiency (36). 
Thus, plasma RBP levels are related to, but not Identical 
with, circulating retlnol concentration#. RBP levels are 
also very sensitive to both short-term protein and energy 
deficiencies and severe caloric and protein malnutrition 
(69-72). These influences limit the usefulness of measuring 
RBP levels alone. 
Other parameters suggested for evaluating vitamin A 
status have included the level of the lysosomal enzymes 
arylsulfatase and acid phosphatase In the urine, and 
depressed alphag-macroglobulin levels In the plasma, but 
neither has proved to be a reliable measure of vitamin A 
status (35,73,74). 
The correlation of urinary and fecal metabolites with 
liver stores at high liver vitamin A concentrations did not 
hold at lower liver vitamin A levels (33,75). Although 
several of these metabolites have been identified, their 
urinary and fecal levels have not been correlated with 
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vitamin A status (33,76-78). 
Another alternative for assessing vitamin A status was 
proposed by Loerch et al. (79). This method has 
been called the relative dose response (RDR). This method 
Is based on the observation that a small oral dose oE 
vitamin A gives a rise In plasma vitamin A at 5 hours for 
rats with low liver stores and plasma vitamin A levels. The 
response Is calculated as RDR(X)*[ (Aj'-Aq)/Aj] K 100, 
where Aj • plasma retlnol level, in ug/dl, at five hours 
after dosing, and Aq • plasma retlnol level, In ug/dl, 
in the Casting subject before dosing. Depending on the 
degree of response, this method Is able to differentiate 
between rats with liver stores less than 20ug/g and those 
with values greater than this concentration. The method 
appears to be reproducible If both plasma and liver vitamin 
A levels are reduced. 
Physiologically this approach is based on the fact that 
when sufficient vitamin A is not present In the liver, 
apo-RBP levels in the liver increase (41,80,81). When 
vitamin A is administered, it immediately associates with 
RBP and is released as the retinol-RBP complex Into the 
plasma (40,82-84). This response contrasts with that of a 
vitamin A-sufficient rat or human, where adequate endogenous 
stores are initially available to maintain the steady-state 
plasma vitamin A levels. In this latter instance, no 
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response Is seen, I.e., RDR-0%. 
The procedure was shown to be most effective for 
discriminating between rats with marginally lowered plasma 
levels (20-30ug/dl) as the result of lowered liver vitamin A 
levels and rats with plasma levels lowered because of other 
dietary restriction. The usefulness of this method has been 
evaluated by dark adaptation tests in patients with 
alcoholic liver disease and cystic fibrosis (83,84). 
Elevated RDR values were found in those patients with 
abnormal dark-adaptation. After vitamin A therapy RDR 
values decreased and dark adaptation improved. However, 
only 50% of those with alcoholic cirrhosis and apparent 
vitamin A deficiency showed an elevated RDR. Another study 
showed that the RDR values failed to predict vitamin A 
status in patients with protein-energy malnutrition and in 
patients with liver dysfunction (85,86). It was postulated 
that this result could be related to impaired RBP synthesis 
and secretion. One recent study on well-nourished surgical 
patients showed that an RDR of greater than 20% may be a 
better indicator of reduced liver stores of vitamin A in 
humans (87). 
From these studies it appears that the RDR value may 
indicate reduced liver stores in non-diseased populations. 
Its usefulness, however, will be limited to a qualitative 
rather than quantitative assessment of vitamin A status, in 
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as much as an exact correlation between RDR values and liver 
vitamin A levels has not been shown. 
As stated previously, the liver is the major storage 
site of vitamin A. Any method which accurately measures 
liver vitamin A levels would be a truly good measure oC 
vitamin A nutriture. Despite concern about the 
extrapolation from dead to living populations, vitamin A 
levels in autopsy specimens have been used as an Indicator 
of the nutritional status of a living population (15,59,61, 
88,89). Liver biopsy samples from live patients may also be 
used, although questions of feasibility and ethics may well 
pertain in such cases. 
Another possibly fruitful approach is the isotope 
dilution assay. In this method isotopically labeled vitamin 
A is first injected or ingested. A plasma or serum sample 
is then taken after the labeled vitamin A has equilibrated 
with the total body stores of vitamin A. On the bases of 
the amount of labeled vitamin A given, an assumed retention 
factor, and the ratio of unlabeled to labeled vitamin A in 
the plasma at equilibrium, the body's total stores of 
vitamin A might well be estimated. 
This method was first used in rats, where a 
physiological dose of tritiated retinyl acetate was given, 
and the specific activities of plasma and liver were 
calculated after 5 days (90). It was shown that the 
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specific activities of plasma and liver were In good 
agreement, an Indication that the dose of labeled vitamin A 
became homogeneously Intermixed with the vitamin A body pool 
(74,75,90). The liver stores calculated from the specific 
activity of vitamin A in the plasma were in excellent 
agreement with the values obtained from direct measurement 
of the liver vitamin A content. This calculation was based 
on the assumption that only a certain percentage of the 
labeled vitamin actually equilibrates with the body stores. 
A certain percentage has been shown to be preferentially 
metabolized before storage, and thus is not available for 
equilibration with the total body pool of vitamin A (74,75). 
Above the level of approximately 18 ug retlnol/g liver, 
50-63% of a labeled dose of vitamin A Is stored In the 
liver. When liver concentrations were between 0.6-l3.5ug 
retlnol per gram liver, however, the percentage of the dose 
that actually equilibrated with liver stores of vitamin A 
ranged from 6 to 40% (74). By using a factor of 0.5 as the 
fraction of the labeled dose stored, a correlation 
coefficient of 0.982 was found between calculated and 
analyzed liver vitamin A values In a group of 140 rats with 
varying degrees of vitamin A stores (18). 
This method, using trltlated retlnyl acetate, was also 
applied to sheep, a piglet and one human subject. A good 
correlation was found in the case of sheep, where the liver 
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vitamin A content could be measured and compared with the 
calculated liver vitamin A content. 
When rata with varying hepatic vitamin A levels were 
3 dosed with a single oral dose o£ 10 or 20ug of 11,12- H2 
retinol and sacrificed seven days later (91,92), a good 
correlation between total liver vitamin A and the ratio oE 
specific activities of the dose and plasma vitamin A was 
found. A plot of log plasma specific activity versus log 
total liver vitamin A also gave a high correlation (r-0.94 
and 0.87 for 10 and 20ug doses, respectively) (91,92). 
For more widespread use in humans and animals, vitamin 
A labeled with a stable Isotope would be preferable. Hughes 
et al. (93) outlined a procedure using 11,12- H2 
retinyl acetate In amounts equivalent to one-fifth to 
one-tenth of the expected stores. After a dose had 
equilibrated for seven days In rats, the plasma retinol was 
Isolated and derlvatlzed, and then the ratio of labeled to 
non-labeled vitamin A was analyzed by gas chromatography 
coupled with mass spectrometry. Exact ratios were obtained 
from a standard curve generated by analyzing known ratios of 
retinol and deuterated retinol. The standard curve was 
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corrected for the natural contribution of C Isotopes. 
By using this ratio and a mean storage factor, the original 
liver stores were calculated. 
This procedure, using the non-radloactlve heavy isotope 
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deuterium labeled vitamin A, gave a strong correlation 
between calculated and experimental liver vitamin A levels 
(r-0.833), but not as strong as that seen with the radio 
labeled assay (r"0.982) (93). The mean storage factor used 
in both experiments was 50% of the test dose. As noted 
previously, the actual percentage Ls dependent upon the 
Initial liver stores o£ vitamin A. 
The deuterium labeled vitamin A was also used In sheep 
and cattle. The mean storage factors best accounting for 
storage of the test dose was 30% in depleted cattle and 40% 
in normal cattle. 
The vitamin A body stores of the same individual 
analyzed with 11,l2-^H2-retinyl acetate was compared 
by using Che deuterated material. A value of 279ug vitamin 
A per gram liver using deuterated vitamin A compares well 
with the 285ug/g obtained by using tritiated vitamin A (93). 
An equilibration period of 17 days was used by this group. 
A 26 day equilibration period was suggested by Sauberlich 
et al. using labeled retlnyl acetate (94). 
The preceding information sparked our interest in this 
methodology because: a) the method yields good estimates 
when an appropriate storage factor is used, b) the procedure 
gives a quantitative estimate of liver reserves, c) and the 
method is Innocuous, except for the need to take a single 
blood sample. 
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In the past, a number of deuterated analogues oE 
vitamin A has been synthesized (Table I). The vast majority 
of these analogues has been produced in order to understand 
the interaction between vitamin A aldehyde (retinaldehyde) 
and the protein opsin via Raman and IR spectroscopy (95). In 
all but a few cases, they represent a single or double 
substitution of a non-labile proton with deuterium In the 
polyene side chain (96-101). The incorporation of deuterium 
at specific positions ranged from 90-99% in these compounds. 
Retinoids in which three or more protons were replaced are 
14,20,20,20-2H4-retlnal (80% (98), 4,4,18,18,18-^H5 
retinolc acid ethyl ester (90% ^Hj) (102), 10,11,12,14,15, 
20,20,20-2Hg-retinal (62% ^Hg) (103), and 18- and 19-
trideutero retinal (98% and 99% respectively) (97). 
Deuterium was incorporated into the above compounds by 
reduction with deuterated reducing agents (e.g., LIAI H^), 
by hydrolysis of reaction intermediates with deuterium 
oxide, or by base-catalyzed exchange of labile protons in 
2 
excess H^O/NaOD. Those methods employing deuterated 
reducing agents are generally high yielding reactions and 
give products with a high deuterium incorporation, generally 
approaching that of the reducing agent itself. Analogues 
containing three or more deuterium atoms were labeled by a 
combination of reduction with deuterium and by base-
catalyzed exchange of labile protons. With the exception of 
18a 
Table I. DeuCerated analogues of vitamin A. Total ZD 
indicates the percent replacement of hydrogen with 
deuterium at the indicated positions 
COMPOUND TOTAL ID CITATION 
I 0 . l l . l 2 , 2 0 . 2 0 , 2 0 - n u  
retlnyl acetaca 
98 Akita, 1983 
(103) 
10,%1,12,14,15,20,20,20-
Hg-retinal 
lO,ll-%-
retlnftl 
14,20,20,20- 2 » , -
retlnal 
10-^H-retinal 
11-^H-retlnal 
20,20,20-2».-
retinal 
20,20,20-2».-
rettnolc acid ester 
14,20,20,20- 2 » , -
retlnyl acetate 
12,14,20,20,20-2» 
retlnyl acetate 
10,19,19,19-2»,-
retinyl acetate 
4,4,18,18,18-2» 
retlnolc ado ester 
62 
97.5 
80 
96 
95 
80 
57 
76 
40 
98 
90.5 
Broek and LuRtenbur^. 
1982 (98) 
I I  
Bergen and Olson, 
(this study) 
•• 
Dawson et 
al., 19H1 (102) 
1 1 , 1 2 - % -
retlnal 
95 Eyring at 
al., 19?0 (ion 
\ H b  
Table I (continued) 
COMPOUND TOTAL ID CITATION 
10-^H-rettnal 
15-^H-retlnal 
IS-^Hj-retlnal 
>82 
99 
98 Franaen êS, al* , 
1980 (97) 
19- Hg-retlnal 
14-^H-rettnal 
lA.lS-^Hg-retlnal 
l5-^H-retlnal 
14,IS-^Hj-retInal 
99 
95 
C-14 95 
C-15 99 
99 
90±3 
Johansen nnd tJanon-
Jensen, > 
## 
Waddell ec al., 
1981 (100) 
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Che trldeucero compounds, deuterium Incorporation only 
approaches that o£ the mono substituted analogues oE 
4,4,18,18,18 retlnolc acid ethyl ester (102), 
where 90% o£ the product exists as a pentadeutero analogue, 
and 10,U,12.20,20,20-^Hg-retlnyl acetate (98% (103). 
The other polysubstltuted analogues show even greater 
contamination o£ the desired product with mono, dl, trl,... 
etc. substituted analogues (98,102). 
The most widely used methods for the synthesis of 
retinoids generally Include a Wlttlg reaction, or a 
modification of a Wlttlg reaction such as phosphoryl-
atablllzed anions and modified reaction conditions 
(104-108). The Wlttlg reaction In Its original form 
involved treatment of a carbonyl compound with phosphonium 
ylides (I) to form an olefin and phosphlne oxide (109): 
One of the early modifications of this reaction was the 
of diphenyl phosphlne oxide carbanlons (II). These 
carbanlons also undergo reaction with aldehydes and ketones 
to form olefins (110): 
20 
RjRjC-O R^RjC-CHR. 
(Ph^gPOg 
A further modlElcaClon was developed by Horner et al. (105) 
and by Wadsworch and Emmons (lit). Called either the 
"modified Wlttlg" reaction, "Wlttlg-Horner" reaction or the 
"Horner-Emmons" reaction, It employs the use of a 
resonance-stabilized phosphonate carbanlon (III): 
Phosphonate carbanlons possess several advantages over 
the phosphonlum ylldes of the Wlttlg reaction: 
a) The phosphonate carbanlon Is more nucleophlllc than the 
yllde and reacts with a wider variety of aldehydes and 
ketones and under milder conditions. 
b) The water-soluble phosphate Ion formed from the 
phosphonates Is easily separated from the olefin In the 
reaction mixture. 
c) The phosphonates are easily prepared from alkyl halldes 
and trlalkyl phosphites. 
d) Sterlc requirements of the Intermediates of this 
reaction often permit the reaction to proceed 
stereoselectively to produce predominantly the trans olefin 
(RO)2?CH2RJ ' (R0)2i*SHRj 
—H 
RmR.C-0 R,R,t>CHR, 
* ^ *• -J 
III (ROOz'Og 
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( 1 1 2 ) .  
Both retinoids and caroCenoids have been successfully 
synthesized by use of one or more of these reactions, as 
recently reviewed (112-113). The starting point of 
synthetic retinoid chemistry is generally the substituted 
cyclohexene ring with a polyene side chain of varying 
lengths, the most common being 2,2,6-trimethylcyclohexanone 
(IV), beta-cyclocitral (V), beta-lonone(VI), 
beta-ionylidoneacetaldehyde(VII), or the C-18 tetraene 
ketone (VIII): 
Or Qc" 
IV VI 
VII 
All of these compounds may serve as substrates for 
addition by a Wittig or modified-Wittig reaction. 
Alternatively, the cyclohexene containing moiety may contain 
the activated phosphoryl activated group. For example, the 
(beta-lonylldeneethyl)trlphenyl phosphonlum hallde (IX) may 
react under appropriate conditions with (E)-4-acetoxy-
2-methyl-crotonaldehyde (X) to give a mixture of 11-cls and 
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all-trans retlnyl acetate (XI) directly (97): 
^ OAc 
OAc 
XI 
In the above example, the phoaphonluro yltde (IX) is 
part oi the beta-lonone ring structure and is added to an 
aldehyde which becomes the terminus of the side chain. Many 
synthetic procedures employing the Vittig reaction or its 
modifications exist in the chemical patent literature. 
Under the influence of dilute alkali or acid, an 
aldehyde or ketone will condense with itself to form a 
beta-hydroxyaldehyde or beta-hydroxyketone, depending on the 
starting material. This reaction is referred to as an aldol 
condensation. The condensation of an aldehyde with a ketone 
generally occurs in very low yield because of the rapidity 
of the self-condensation of the aldehyde. This problem can 
be overcome by use of the directed aldol condensation, where 
the aldehyde is first blocked by the formation of a Schiff 
base (imine). The anion of the Schiff base can then be 
added to another carbonyl compound giving a beta-hydroxy 
Imlne. Dehydration of this alcohol and hydrolysis of the 
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imlne resulcs in an alpha,beca-unsacurated aldehyde (116). 
Tanls GÇ al. (117) used this reaction scheme to 
produce 10,14-dlmeChyl retinal. Starting with beta-ionone 
(VI) and propylidene cyclohexylamine, they carried out a 
directed aldol condensation followed by dehydration of the 
beta-hydroxy IraLne and then, by hydrolysis of the Schtff 
base, obtained the C-16 aldehyde (XII): 
VI / 
CHO 
XII 
Condensation of (XII) with acetone in the presence o f  
base gave the C-19 ketone (XIII): 
XIII 
Repeating the directed aldol condensation with propylidene 
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cylcohexylamine gave, after purification, the desired all 
trans 10,14-dimethyl retinal (XIV) in relatively low yield 
(2.2% all-trans + 12% cis): 
Basic to any labeling scheme, whether it be with 
radioactive or stable Isotopes, is that the label is 
generally Introduced at or near the end of the reaction 
sequence. The possibility of losing labeled material in 
subsequent steps is thus avoided and, in the case of 
radioactive labels, less manipulation of radioactive 
material is necessary. For biological use, the site of 
labeling becomes important. Labels introduced into 
metabollcally active sites or into sites where there is free 
exchange with solvent protons may or may not be beneficial, 
depending on the experimental requirements. When only I or 
2 stable isotopic atoms are Introduced into an organic 
compound, the molecular ions that are measured (M+l, M+2) 
XIV 
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also contain contributions from the same compound labeled 
with naturally occurring isotopes. For example, in the case 
of retinol, a C-20 compound, the natural abundance 
1 1 
contribution of C is 22% of the molecular ion (M) at 
M+l and 4.8% at M+2. Increasing the molecular weight by 
three or four amu increases the sensitivity of the analysis 
by allowing measurements of the labeled compound without 
these interfering ions (118). 
Work presented here shows several synthetic routes for 
the preparation of deuterated analogues of vitamin A. In 
the preparation of these deuterated analogues, use has been 
made of both the directed aldol condensation and the 
Wittig-Horner reaction 
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MATERIALS 
Compounds employed and Chelr suppliers, given in 
parentheses, were: Deuterium oxide (98.8%) (Columbia 
Organic Chem. Co., Columbia SC); perdeuceroacetone (99.8%) 
(Norell, Inc., Landisville, NJ); NaO^H (40%, 99+ atom % 
2 2 H), deuterium oxide (99.8 atom % H), diisopropyl-
amine (991), triethyl phosphite (99%), ethylbromoacetate 
(97%), Mn02(IV) (activated), beta-ionone (98%), n-butyl 
lithium (1.6M in hexane), trimethylchlorosilane, 
hexamethyldisilazane, and trimethyl silyl diethylamine (97%) 
(Aldrich Chem. Co., Milwaukee, Wis); hexanes, ethyl ether 
(anhydrous), acetic anhydride, magnesium sulfate (powder), 
ethyl acetate, and acetaldehyde (Fischer Scientific Co., 
Pittsburgh PA); N-methyl-N-trimethyl silyltrifluoro 
acetamide, N-tri-oethylsilyl diethylamine, and Reacti-Vials 
(Pierce Chem. Co., Rockford, 111); N,0-bis 
(trlmethylsilyl)"acetamide, N,0-bis(trimethylsllyl) 
trifluoroacetamide, and t-butylsilyl-imidazole dimethyl 
formamide (Supelco, Inc., Bellefonte, PA); Silica gel 60 
(70/270) mesh and Polygram SiL G/UV254 40x80mm TLC plates 
(Machery Nagel, Duren, Germany); retinol and retinyl acetate 
(Sigma Chem. Co., St. Louis, MO); alpha-tocopherol and 
cyclohexylamlne (Eastman Kodak, Rochester, NY); 
tetrahydrofuran (Malllnckrodt, Inc., Paris, fCY) ; straight 
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phase u-Porasil HPLC columns (Waters Assoc., Mllford, MA); 
reversed phase Partlsll ODS-2 HPLC columns (Whatman, Inc., 
Clifton, NJ). 
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METHODS 
Synchesis of Deuceraced Analogues of Vitamin A 
Synthesis of 20.20.20 Trideuteroretinol Via A Directed 
Aldol Condensation 
Preparation of ethylidenecyclohexylamine The 
amine was synthesized by the published procedure (116). 
Briefly, in a 0.5-liter, three neck flask, 99.2g (Imol) of 
distilled cyclohexylamine is cooled to -20*C in a dry 
ice/acetone bath. Upon the addition of freshly distilled 
acetaldehyde (residual acetic acid inhibits this reaction) 
from a dropping funnel, a white solid forms. Anhydrous 
sodium sulfate (20g) is then added. The reaction mixture is 
allowed to warm to room temperature, the solution is 
filtered, and the solid residue washed with ethyl ether. 
The ether washes are then added to the product. The ether 
is removed by rotoevaporatlon, and the product is purified 
by vacuum distillation. The yield of ethylidene­
cyclohexylamine Is 50-70%. 
Preparation of all-trans beta-ionylldene 
acetaldehyde In an Ice bath under positive nitrogen 
pressure, 37.5mmol of n-butylllthlum In hexane (titrated 
according to the method of Watson and Eastham (119)) Is 
added dropwlse to a solution of 3.79g dllsopropylamlne in 
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30ml ethyl ether. After the reaction mixture was stirred 
for another 30 minutes at 0*C, ethylidenecyclohexylamine 
(4.56g, 0.037Sool) In 30ml ether is added dropwise. The 
solution is stirred for an additional IS minutes, is then 
cooled to -70*C for one hour, and then is allowed to warm to 
room temperature. The mixture is then cooled again in an 
ice water bath, and the reaction is quenched by the addition 
of 50ml water. The organic layer is separated and dried 
over NagSO^. After removal of the solvent, the 
product is taken up in 100ml tetrahydrofuran (THF) and 
cooled in a dry ice/acetone bath. Iodine crystals (ISmmol, 
3.75g) are added, and the reaction is stirred for 30-60 
minutes. The reaction mixture is then allowed to warm to 
room temperature. The iodine is removed by sequentially 
washing with water (3X500ml), 5% NaHSOg (2X200ml), water 
(2X300ml), and saturated NaCl solution (lX400ml). The 
organic layer is collected and dried over Na2S0^. 
The solvent Is removed in vacuo to yield a dark orange 
yellow oil, which Is filtered through an open silica gel 
column (25g) with 25% ethyl acetate/hexane. The eluant is 
collected, and the solvent is evaporated off to yield an 
impure mixture of els and trans Isomers of beta-ionylidene 
acetaldehyde, unreacted beta-ionone and other side products. 
By analysis of this mixture on straight phase HPLC (5% 
ethylacetate/hexane), the all-trans form of 
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beCa-Lonylldene acecaldehyde was idencl£ied as the major 
Isomer (60% trans. 40% cts). The estimated overall yield oE 
cis and trans isomers of beta-ionylidene acetaldehyde from 
beta-ionone was 30%. The aldehyde can then be purified by 
straight phase HPLC (5% ethylacetate/hexane). 
Preparation of C-18 tetraene ketone A solution 
of 3g beta-ionylLdeneacetaldehyde In 100ml acetone Ls 
stirred with 32ml IN NaOH for 6-18 hours. Th«t solution Ls 
poured into 800ml ether and washed with 6X400ml water. The 
ether layer Is dried (NagSO^) and concentrated on a 
rotary evaporator. The estimated yield from 
beta-ionylideneacetaldehyde Is 80%. Purification Is 
accomplished by preparative straight phase HPLC (5% 
ethylacetate/hexane). 
Preparation of trideutero C-18 tetraene ketone 
(120) To a stirred solution of 5ml of dioxane and Ig 
of the C-18 tetraene ketone is added 30g of deuterium oxide, 
into which Ig of sodium metal had been carefully added in 
small pieces. This solution, after being allowed to stir 
overnight, is poured into 100ml ethyl ether and extracted 
with 50ml IN HCl, 50ml water and 50ml saturated NaCl. The 
organic phase is then dried over Na2S0^. The reaction Is 
repeated. The final product may be filtered through silica 
gel (25% ethylacetate/hexane). Mass spectral analysis shows 
>95% deuteration. The estimated yield is 40%. 
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Preparation of 20,20,20-rettnaldehyde 
Dilsopropylamine 0.2ml (1.43 mMoles) in 25ml ethyl ether is 
cooled in an ice water bath. Under a slight positive Ng 
pressure, 1.43 mMoles n-butyllithium in hexane is added 
dropwise and stirred for 5-10 minutes. After the addition 
of ethylidenecyclohexylamine in 2ml ether, the solution la 
stirred for 15 minutes at 0°C and then is cooled In a dry 
ice/acetone bath. To this cooled solution is added 0.37g 
trideutero C-18 tetraene ketone in 2ml ethyl ether. The 
solution is stirred for thirty minutes and then Is allowed 
to warm to room temperature. After cooling again In an Ice 
water bath, the reaction Is quenched by the addition of 7ml 
of water. After the solution is stirred for 5 minutes, the 
organic layer is separated, dried (NagSO^) filtered 
and evaporated. 
The residue is then taken up in 5ml of THF and cooled 
to -23°C in a dry ice/acetone bath. Iodine (0.12 moles, 
0.03g) is added In three portions, and the reaction Is 
stirred for one hour and then allowed to warm to room 
temperature. At this point, a tar-like polymeric substance 
appears. The reaction mixture and as much residual material 
as possible is poured into a mixture of 15ml ethyl ether and 
10ml water. The reaction flask is rinsed several times with 
ether, and the rinses are added to the ether-water mixture. 
The ether layer is separated and washed with 3xl5ml water. 
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15ml SX NaHSOj, 2X15ml water, and 15ml saturated NaCl. 
The ether solution is then dried (Na2S0^) and rotary 
evaporated. The hexane-soluble part of the residue is 
filtered through a column of 2.5g silica gel with 25% 
ethylacetate/hexane. The product, trideuteroretlnaldehyde, 
eluted at the same retention time as standard retLnaldehyde 
on straight phase HPLC. By increasing the amount of 
starting materials, enough trideuterated retinal was 
obtained to allow NMR and mass spectral analysis. The 
estimated yield from beta-lonone Is 1%. Deuterium 
Incorporation was >90% by mass spectral analysis. 
Synthesis of 20.20,20 Trldeuteroretlnyl Acetate 
Preparation of trlethylphosphonoacetate (121) 
Freshly distilled ethylbromoacetate (300g) Is added dropwlse 
to previously distilled trlethlyphosphlte (300g). After the 
addition of approximately 75g of ethylbromoacetate, an 
exothermic reaction begins and bromoethane begins to distill 
off. If the exothermic reaction does not begin 
spontaneously, the flask Is gently heated until It does. 
The remaining ethylbromoacetate Is added slowly and 
carefully to maintain the reaction temperature until all of 
the ethylbromoacetate has been added. The mixture is then 
heated until all the bromoethane has distilled. The 
remaining product is further heated at 170°C for five hours. 
Vacuum distillation of the product yields 
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trieChylphosphonoacetate In 80-90% yield. 
Preparation of ethyl beta-ionylideneacoCata 
Sodium hydride (37.Ag, 1.56mol as a dry powder) is weighed 
under an inert atmosphere (nitrogen) into a two liter round 
bottom flask, and then is covered with 300ml dry ethyl 
ether. To this stirred suspension, 349.7g 
triethylphosphjnoacetate (1.56mol) is added in 100ml ethyl 
ether from a dropping funnel. From an Initial cloudy 
solution of suspended NaH, the mixture turns to a clear 
amber color after approximately two hours. To this solution 
is added dropwise lOOg beta-ionone in 200ml ethyl ether. 
The reaction mixture is stirred overnight. Although a solid 
precipitate forms in some cases, this precipitate in no way 
affects the completeness of the reaction, as measured by TLC 
(silica gel, 201 ethylacetate/hexane). When all material 
with an Rf corresponding to beta-ionone is gone, 200-300ml 
of water are added at a rate which prevents the solution 
from boiling over. The solution is then poured into 800ml 
hexane and washed with several volumes of water to remove 
the water-soluble side products. The organic layer is dried 
(MgSO^), filtered, and concentrated in a rotary evaporator. 
The yield of all-trans ethyl-beta-ionylideneacetate is 
92%. 
Preparation of beta-ionylideneethanol Lithium 
aluminum hydride (12.8g, 95%) is covered by 0.5 liter of 
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anhydrous eChyl ether In a two-liter round-bottom flask 
containing a stirring bar, and the solution is cooled in a 
dry ice/acetone bath to -70*C. To this cooled stirred 
solution is added dropwise 80g of ethyl-beta-lonylidene-
acetate in 300ml ethyl ether. The solution is stirred for 
one hour and then is allowed to warm to room temperature. 
The conversion of the acid ester to the alcohol is checked 
by TLC. If some of the acid ester remains, the solution is 
again cooled and additional LIAIH^ is added in small 
amounts until all of the ester has been reduced. When the 
ester is completely reduced, the mixture is again cooled, 
and IN H^SO^ is added dropwise to deactivate any 
remaining LIAIH^ and to dissolve the voluminous aluminum 
hydroxide precipitate. If too great an excess of LlAlH^ 
is present, deactivation could result in the flask contents 
boiling over. After careful attention to deactivation, the 
organic layer is poured into 500ml ethyl ether and washed 
several times with IN HgSO^ and water. The organic 
layer is then dried (MgSO^), filtered and rotary 
evaporated to yield 60.Ig beta-lonylldenethanol (89.5%). 
Only minor impurities are present. 
Preparation of beta-lonylldene acetaldehyde 
Beta-lonylldenethanol (55g, 0.25mol) Is stirred in 1.5 liter 
of hexane. Manganese IV oxide (275g) Is added while 
stirring. This suspension Is stirred overnight and checked 
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by TLC for completion of the oxidation. The solvent Is 
removed by vacuum filtration, and the manganese dioxide Is 
washed with methylene chloride until no remaining aldehyde 
can be detected (TLC). The filtrate Is reflltered to remove 
any fines and rotary evaporated to obtain, with only minor 
Impurities, 51.5g beta-lonylldene acetaldehyde. The yield 
is 94.5%. 
Preparation of C-18 tetraene ketone Bota-
ionylidene acetaldehyde (45g) in 1500ml acetone is treated 
with lOOml IN NaOH and then is stirred for 5 hours. The 
resulting solution is divided in half, and each half is 
poured into one liter of hexane, washed with water 
(6X1000ffll), dried (MgSO^), and filtered. Recombination 
of the solutions and removal of the solvent by 
rotoevaporation gave 48.9g C-18 tetraene ketone (20% cis. 
80% trans). a 92% yield. Several minor spots that appear on 
TLC constitute 2% of the total. 
Preparation of trideutero C-18 tetraene ketone 
Either all-trans C-18 tetraene ketone (llg) purified by 
straight phase HPLC (2% ethylacetate/hexane) or the crude 
cis/trans mixture (ca. 80% trans) is dissolved in 60ml 
freshly distilled pyridine. Deuterium oxide (99.8%, 28g) 
2 
and 10 drops of NaO H (40%) are added, and the mixture 
is stirred for one hour. The mixture turns a dark red. As 
indicated by TLC analysis, some of the ketone is degraded 
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during Che step. The reaction mixture Is then poured Into 
400ml hexane, and the aqueous layer Is removed. The organic 
layer Is then repeatedly washed (4-6X400ml water) until the 
pyridine is removed, is dried (MgSO ), and is concentrated 
by rotary evaporation. The reaction is repeated one or two 
times or until the deuterium incorporation is >98% (checked 
by NMR or MS). This deuteration step yields, after 
purification, 6.82g (621 yield) trideutero C-18 tetraene 
ketone (^Hj >95%). 
Preparation of 20.20.20-^Hj Retinoic Acid 
Ethyl Ester Sodium hydride (l.38g) as a dry powder 
is weighed in an inert atmosphere into a one-liter 
round-bottom flask equipped with a stirring bar and is 
covered with 250ml anhydrous ethyl ether. 
Triethylphosphonoacetate (I2.88g, 0.057mol) is added 
dropwlse from a dropping funnel in 200ml ether at a rate 
which allows for the slow evolution of hydrogen gas. The 
initial cloudy suspension becomes clear and amber in color 
2 
after stirring for 2 hours. 18,18,18- H^-tetraene 
ketone (5g, 0.0l9mol) is then added dropwlse from a dropping 
funnel In 50ml anhydrous ether. The reaction mixture is 
allowed to stir overnight, at which time lOOml HgO is 
added to quench the reaction. The solution is poured Into 
one liter of hexane and washed with H2O (5X700ml). The 
organic layer Is dried (MgSO^) and rotary evaporated to 
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2 
rotary evaporated to yield 20,20,20- H^-retinolc 
acid ethyl ester (A.08g, 0.012 moles) In 65% yield (60% 
trans, 40% c^) as determined by UV absorption at 350nm 
(c-45,600). The deuterium Incorporation la: Hg"6.3A%, 
^H^-6.8%, ^ H2-30.0%, ^ H3-56.9%. 
Preparation of 20.20.20-^Hj Retlnol LIAIH^ 
(0.57g, 0.015 moles) Is stirred In 250ml anhydrous ethyl 
ether and cooled to -70*C In a dry Ice/acetone bath. 
20,20,20-^H2-Rettnolc acid ethyl ester (5g of the 
crude material) Is added dropwlse In 100ml ethyl ether. 
After stirring 30 minutes at -70*C, the solution Is allowed 
to warm to room temperature. Reduction of the starting 
material is checked by TLC. Additional LIALH^ is added 
at -70*C if the reduction is not complete. The solution is 
quenched by adding IN H^SO^ dropwlse to the cooled 
solution. The quenched mixture is warmed to room 
temperature, is washed first with IN HgSO^ (2X200ml) 
and then with HgO (3X200ml), is dried (MgSO^), and 
is rotoevaporated to give 3.65g (85% yield) of crude 
20,20,20-2H3-retinol. 
Preparation of 20,20,20-^H2-Retinyl Acetate 
20,20,20-^H2-Retinol (Ig) is dissolved in 10ml 
pyridine and cooled in an ice bath. Acetic anhydride 
(0.28ml, 0.003 moles) is carefully added drop by drop. 
After stirring for 10-15 minutes, the solution is allowed to 
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warm to room temperature and is checked by TLC £or unreacted 
alcohol. l£ the acetylation is not complete, the solution 
is cooled and more acetic anhydride is added. Thereafter, 
residual acetic anhydride is destroyed by the addition of 
ice crystals. The solution is poured into 250ml hexane and 
washed with water (6X250ml) to remove the pyridine. The 
organic layer is removed, dried (MgSO^), and 
rotoevaporated to give an estimated crude overall yield of 
60% (40% els, 60% all-trans). The isomers can then be 
separated by straight phase HPLC (2% ethylacetate/hexane). 
2 Isomerization of 13-cis- H^-retinyl acetate 
2 All-trans Hj-retinyl acetate can be prepared 
from the c^ isomers by dissolving up to Ig of the cis 
Isomers In lOOml hexane and adding a small crystal of 
iodine. After stirring for one hour under gold fluorescent 
lights (Westlnghouse F40 Gold), the organic layer Is washed 
with lOOml of 5% NaHSOg then with water (2Xl00ml), and 
then Is dried (MgSO^). The all-trans ester Is 
purified from the equilibrium mixtures (35% l3-cls, 55% 
all-trans, 10% other els forms) by straight phase HPLC 
(2% ethylacetate/hexane). 
Preparation of 14,20,20,20 Tetradeutero Retlnyl 
Acetate Via a Wlttlg/Horner Reaction 
The preparation of this tetradeuterated species Is 
Identical to that of 20,20,20 trldeuteroretlnyl acetate. 
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wich Che excepClon chac dldeucerocrlechylphosphonoacecace is 
used In place of Che phosphonace carbanion in Che final 
Wiccig/Horner reaccion of Che synchesis scheme. 
Preparacion of dldeucerocriechylphosphonoacecace 
Triechylphosphonoacecace (17Sg) is scirred wich 310g 
deucerium oxide and 5mL 40% NaO K for Cwo hours. The 
reacClon olxCure is poured Inco 500ml echyl echer, and Che 
aqueous layer is exCracCed wich eChyl eCher (5X300ml). The 
combined eCher excraccs are dried (MgSO^) twice. The 
deuceraced phosphonace, recovered afcer rocary evaporaclon 
of Che solvenC, is again dissolved in deucerium oxide (200g) 
2 
and sCirred wich 70 drops of 40% NaO K for cwo hours. 
Afcer excraccion wich echyl echer by Che same procedure, 
151.9g (87%) dideucerocriechylphosphonoacecace are 
recovered. NMR shows a >99% dideuceraced species. 
When dideuCeraCed CrieChylphosphonoaceCaCe is 
condensed wich Che CrideuCero C-18 cecraene kecone, 
14,20,20,20 cecra deuCerated retinoic acid echyl ester ts 
formed wich Che following deuterium content, as determined by 
mass spectrometry: ^^*76%, ^H2'"3%. 
Preparation of 12,14,20,20,20 Pentadeutero Retinyl 
Acetate via a Wlttlg/Horner Reaction 
The procedure outlined for the synthesis of 14,20,20,20 
tetradeutero retinyl acetate Is used with the following 
modification. Beta-lonylldeneacetaldehyde (5g) Is dissolved 
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2 in 80g acetone and stirred during the addition 
o£ 2ml IN Na0^H/^H20. The solution is stirred 
for 12 hours and then poured into 300ml hexanes and 20ml IN 
H2SO4. The hexane layer is collected, dried 
(MgSO^), filtered and rotary evaporated under high 
vacuum. The product, tetradeuterated C-18 tetraene ketone, 
is reacted with the deuterated triethylphosphonoacetate 
carbanion to yield pentadeuterated ethylretinoate. After 
reduction and acetylation, the resulting 12,14,20,20,20-
pentadeutero retinyl acetate showed the following deuterium 
2 2 incorporation by mass spectrometry: Hq-0.05%, H^»3.75X, 
^H2-11.3U,  ^83-18.33Z,  ^H^-27.05%, ^85-39.5! .  
Preparation of 10,19,19,19 Tetradeutero Retinyl 
Acetate 
Preparation of 13.13,13-trldeutero beta-lonone 
Trldeuterated beta-lonone is synthesized according to the 
procedure of Johansen and Llaaen-Jensen (122). Briefly 50g 
beta-lonone is stirred with I56g deuterium oxide. The 
emulsion that forms is dispersed by adding freshly distilled 
pyridine until the solution clears. Then 50 drops of 40% 
2 NaO H Is added, and the solution Is stirred for three 
hours. The solution is poured into 500ml hexanes, and the 
aqueous layer is removed. The organic layer Is first washed 
repeatedly (6X400ml water) to remove the pyridine, and then 
Is dried (MgSO^), filtered, and rotoevaporated. The 
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deuceracion reaction is repeated once. The isolated product 
is 45g (90% yield) of 13,13,13 trideutero beta-ionone with a 
2 deuterium incorporation of >98% H^, as measured by 
NMR. 
Preparation of 10,19,19,19-tetradeuterated Retinyl 
Acetate 
The trideuterated beta-ionone is used in a 
Wittig/Horner reaction with deuterated phosphonate to give 
tetradeuterated ethyl beta-ionylideneacetate. The methods 
for the synthesis of 20,20,20 trideutero retinyl acetate are 
used to complete the synthesis, except that non-deuterated 
reactants are employed for the remaining addition reactions. 
Deuterium incorporation, as measured by NMR and GLC-MS, is 
>98% In the final product. 
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Gmm Chromatography o£ RecLnol Derivatives 
Columns and Packings 
Packed column Silylated glass columns, six or 
three feet long, 2mm I.D., were used in conjunction with a 
Carlo Erba model 4130 gas chromatographic system. Columns 
were packed with 3% OV-lOl on 80/100 Supelcoport (Supelco, 
Inc.) or 31 SE-30. More recently 10% Silar IOC on 100/120 
GasChrom-Q (Anspec, Inc.) has been used effectively. 
The injector was used either with a silylated glass 
insert, or with the inlet side of the columns placed 
sufficiently high in the injector port to insure that the 
syringe needle inserted directly into the upper two inches 
of the column. The injector temperature was 200®C. 
Columns were coupled to a flame ionization detector 
(FID) directly or by a short length of deactivated vitreous 
silica tubing (0.35ms ID, SGE) and swagelock fittings. FID 
settings were 30ml/mln hydrogen and 300ml/mln air at 
230®C. Carrier gas flow was adjusted to 30ml/mln helium at 
the initial temperature in all cases. 
Capillary columns Flexible fused silica 
capillary columns (0.25mm ID, 12 and 15 meters long) were 
used with methyl silicon (O.l or 0.25um film) bonded phase 
coatings (DB-5, J&W Scientific Inc; 007 Methyl Silicon, 
Quadrex). Injection onto these columns was carried out by 
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two methods. The first injection technique used a modified 
splitless injection, where the column temperature was not 
lower than the boiling point of the injected solvent and 
where the injection sample was not split before entry into 
the column. The second injection method employed a dry 
column Injector (Ray Allen, Denver, Co.). In this Injector, 
a vented stream of helium evaporates the solvent as the 
sample is applied via a syringe to a glass probe. Once the 
solvent Is completely evaporated, the vent Is closed and the 
glass probe Is inserted Into the heated Injector block, 
where the dried sample is vaporized and carried Into the 
abutting capillary column. Packed columns were also 
attached to the dry column Injector by a length of 
deactivated vitreous silica tubing. 
Detection for capillary column chromatography was by 
flame Ionization (hydrogen 30ol/mln, air 300ol/mln) or by 
attaching the capillary to a heated (200°C) all glass MS 
Interface. The capillary effluent flows through glass 
tubing in the interface to the ion source, or the column 
outlet can be positioned next to the ion source itself. 
Carrier gas flow was adjusted to 2ml/min in all cases. 
Derivatives 
Standards Standard solutions of TMS-retinol 
were prepared by placing 25mg of crystalline retinol in an 
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amber vial and adding 250ul crimechylsilyldiechylamine 
(TMSDEA). After being warmed in a heating block (45*C) for 
IS minutes» unreacted TMSDEA was removed from the solution 
by passing a stream of argon over the surface. The residue 
is then dissolved in 2ml hexane. This stock solution Is 
stable for one month at -20*C. Working solutions are made 
from the stock solution. Little or no free retlnol was 
present, as measured by HPLC (Whatman ODS-2, 95/5 
MeOH/Water). The formulas and boiling points of sllylatlng 
agents used In this study are given In Figure 1. 
DérivâtIzatIon of samples containing less than lOug 
retlnol 
N.O-bis(trimethylsilyl)acetamlde (BSA) (Figure 
lA) The sample (200ul) to be dérivâtIzed Is dried 
(MgSO^), transferred to a 0.3ml conical Reactl-Vlal, and 
concentrated Just to dryness. BSA (35ul) Is added, vortexed 
to ensure reaction with adsorbed retlnol, and warmed to 45"C 
on a heating block. After removal of BSA with a stream of 
argon, the residual material is dissolved In a 10 to SOul 
portion of hexane. For injection into the gas 
chromatograph, up to 50ul is used in the case of the dry 
column injector and leas than lOul in the case of packed 
columns. 
N-Methyl-N-trimethylsilyltrifluoroacetamide 
(MSTFA) (Figure IB) Retinol (20ug), in up to 200ul 
45 
S1(CH,), 
0 ^ 
CHg-C-N-SlfCH])] 
N,0-bia (TrimeChylsllyl)-aceCaffllde (BSA) 
bp 7l-73*C/35mm Hg 
B 0 CH. 
II I 
CF^-C-N-SifCH^)] 
N-MeChyl-N-trlinethyl sllyl CrifluoroacetamLde 
(MSTFA) 
bp 132*C 
Sl(CH,). 
0 ^ ^  
CF^-C-N-SlfCH})] 
N,0-bl8(triniethylsllyl)trlfluoroacetafBlde (BSTFA) 
bp 40®C/I2n« Hg 
(CH3)3SIN(C2H5)2 
N-trlmethylsllyl dlethylamine (TMSDEA) 
bp 127*C/738mm Hg 
(€#3)35101 
Trlioethylchlorosllane (TMCS) 
bp 57*C 
(CH3)3SlNHSi(CH3)3 
Hexamethyldlsllazane (HMDS) 
bp 126®C 
Figure 1. Silylating reagents used for the synthesis of 
triraethylsilyl derivatives of vitamin A alcohol 
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hexane, is placed in a 0.3ml conical Reacci-Vial and mixed 
with Sul or lOul MSTFA. The solution is then dried under a 
stream of argon with mild heat. The derivative is dissolved 
in 20 to 30ul hexane and injected onto a gas chromatographic 
column. 
N.O-BisCTrimethylsilyDtrifluoroacetamlde 
(BSTFA) (Figure IC) BSTFA was used In place of BSA 
under identical reaction conditions. No TMS-retinol was 
recovered with this reagent. 
Trifflethylsilyldiethylanine (TMSDEA) (Figure ID) 
The sample to be derivatized Is transferred in an anhydrous 
state to a 0.3ml conical Reactl-Vial and concentrated Just 
to dryness under a stream of argon at 45®C. Freshly 
distilled TMSDEA (lOul) Is applied gently from a syringe to 
the walls of the vial to coat all surfaces. The vial Is 
vortexed for two seconds. After being dried under argon, 
the derivatized retlnol Is taken up In an Injectable volume 
of hexane (5-20ul). 
Chromatographic conditions 
Packed columns (3ft) of 3% OV-101 with helium flows of 
30ml/mln and an Isothermal temperature of 230*C gave 
TMS-retlnol retention times of four to five minutes. A 10 
minute retention time for TMS-retlnol was found with a 10% 
Sllar IOC column (3ft., 130-230*C 0 8®C/mln, 30ml/mln 
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argon). Rapid Increases In column temperature of 8*C/min or 
more were used to elute TMS-retlnol as rapidly as possible. 
All packed columns tested required an oven temperature of 
200*C for elution of trimethylsilylretinol. 
Methylsilicon capillary columns of less than fifteen 
meters were used in conjunction with an injector in the 
splitless mode or with a dry-column Injector. Initial oven 
temperatures and gradients for the methylsilicon capillary 
columns were 200'c and 2-lO®C/mln, respectively. By using 
these conditions, TMS-retlnol eluted In 2.2 minutes 
(10*C/mln). Initial oven temperatures lower than 200®C 
resulted In Increased on-column degradation of TMS-retlnol, 
evidenced by Irregular peak shapes, decreased peak areas, 
Isomer formation, and a leading edge on the TMS-retlnol 
peak. Deactivation of both packed and capillary columns by 
the Injection of large (l0-20ug) quantities of TMS-retlnol 
prior to analysis resulted In Increased peak areas of 
standard solutions when compared with standards Injected 
before deactivation. 
Mass spectrometry 
An ExtraNuclear SpectrEl 275 mass spectrometer equipped 
with an electron impact ionization source, all glass gas 
chromatograph interface, and an ExtraNuclear EL 1000 data 
system for data collection was used for mass analysis. 
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Analysis was done ac an Ionization voltage of 70-90 eV, and 
the ion source was tuned to maximize the response to mass 
fragments of m/z 219 and m/z 264 in the calibration gas, 
perfluorotributylamine. The ion source temperature, which 
could not be directly controlled by the operator, was heated 
by the GC effluent and the ionization filament. 
Scanning was done in two different modes. In the first 
mode, a range of 2S0-370amu was repeatedly scanned with a 
2.0 msec/amu dwell time. For quantitation and integration, 
appropriate masses within this range can be plotted and 
evaluated. In the second mode, simultaneous ion monitoring 
(SIM) was employed for masses 255,259,358,362, and 73. A 
200msec dwell time was selected for masses 255 and 259, and 
a 100 msec dwell time for all other masses. In this mode, 
the mass filter moves directly to the selected masses and 
dwells there for the specified amount of time. In most 
cases, this procedure increases detection sensitivity by an 
order of magnitude. 
Purification and quantitation of plasma retlnol 
High performance liquid chromatography A 
Laboratory Data control (LDC) Constametrlc model IIIG HPLC 
pump equipped with a Rheodyne Injector (200ul or 2ml sample 
loop) was used at a flow rate of 2ml/mln. Whatman PartisII 
PXS-10/25 ODS-2 (4.65mm X 25cm) reverse-phase analytical 
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columns were used with a mechanol/wacer (95/5) mobile phase. 
A 2 cm precolumn was also used (Uptight Precolumn, Upchurch 
Scientific, Inc.) packed with CO:PELL ODS (Whatman, Inc.). 
Detection was with a Laboratory Data Control Spectromonitor 
III variable wavelength detector, set at 32Snm. A 
strip-chart recorder (Houston Instruments) as well as a data 
processor (Chromatopac C-2A Reporting Integrator, Shimadzu 
Scientific, Inc.) was used for data collection. At 9-10 
minutes after Injection, the wavelength ia manually changed 
to 292nm In order to monitor tocopherol levels. The 
detector is re-zeroed to the original baseline. 
Sample preparation Samples were treated 
according to the method of Driskell et al. (123). 
Briefly, lOOul plasma or serum is added to lOOul of retinyl 
acetate (0.6ug/ml) in absolute ethanol in a l2X75mm culture 
tube. The mixture is vortexed for 5-lOsec, 200ul hexane is 
added, and the mixture is again vortexed for 30-608ec. The 
tube is stoppered and centrifuged for 3mln. A Pasteur 
pipette is used to transfer as much of the hexane layer as 
possible to a 12X75mm culture tube. The tube is placed in a 
45*C heating block, and the hexane is evaporated under a 
stream of argon. Ethanol (lOOul, 95%) is added, and the 
tube is vortexed. An aliquot of this sample (70-80ul) is 
then injected into the HPLC. For larger samples the same 
ratios of sample to extraction solvents are employed. 
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Qtianeltfttlon Standard curves were prepared from 
standard solutions containing 0.1, 0.225, 0.3, 0.45, and 
0.60ug/ml retlnol and 0.6ug/ml retlnyl acetate. Samples oE 
50ul were Injected to prepare the standard curve. Area 
ratios (from the Integrator report) or peak-height ratios 
(from the integrator report or by actual measurement) o£ 
different amounts of retlnol to Internal standard (retlnyl 
ester) and tocopherol to Internal standard were plotted 
against retlnol or tocopherol concentrations to obtain 
standard curves. 
Sample recovery The retlnol fraction from the 
HPLC eluant Is collected In a l3Xl00mm culture tube. After 
the addition of 2»l hexane and l.5»l water, the tube is 
vortexed, stoppered and centrifuged to facilitate phase 
separations. The hexane layer is transferred with a Pasteur 
pipette to another l3Xl00mm tube and vortexed after adding 
approximately lOOmg MgSO^. The tube is stoppered and 
centrifuged. The hexane layer is decanted Into a lOX75ram 
culture tube, placed in a heating block at 45®C, and 
concentrated to approximately 300ul under a stream of argon. 
This volume is transferred to a conical Reacti-Vial for 
dérivâtization. 
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RESULTS 
The Synthesis of DeuCerated Analogues of Vitamin A 
The Synthesis of Vitamin A via WittIs'a Directed Aldol 
Condensation (Figure 2) 
Twelve months were Invested In duplicating the 
published synthesis of Tanls et al. (117). Although 
the synthesis Is possible, as production of the 20,20,20-
2 
Hg-retlnal Indicates (Figure 4), the two Iodine 
dehydration steps of the beta hydroxy adducts and the 
deuterium exchange all proceeded In very low yields due to 
degradation of either precursors or product. This 
degradation became most apparent In the dehydration and 
hydrolysis of the 20 carbon hydroxylated precursor of 
retinal. In the course of the dehydration reaction, an 
ether-insoluble reddish-black tar formed in all cases. 
Attempts to alter temperature, reaction times, and iodine 
concentration resulted either in no dehydration or in the 
appearance of the polymeric by-product. This by-product 
presumably was iodlnated material. Inasmuch as the iodine 
color completely disappears after reduction with NaHSO^. 
Paratoluene sulfonic acid, a common dehydrating reagent, did 
not give rise to polymeric by-products, but rather produced 
no discernible dehydrated product. In communication with 
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Figure 2. Synthesis of 20,20,20- H^-retinal via a directed 
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the author, the reaction conditions employed here seemed to 
be identical with those used by him (120). In their case, 
however, propylidenecyclohexylamine was employed to 
synthesize methyl-substituted retinal analogues. Quite 
possibly, hydroxylated intermediates of the methyl retinals 
are more readily dehydrated than are analogous intermediates 
in the synthesis of retinal. 
The deuterium-exchange reaction in dioxane also proved 
to be difficult. The C-18 tetraene ketone is a much less 
stable compound than its precursor beta-lonone. Under the 
basic conditions of the deuterium exchange, in which the 
labile alpha protons are removed, the tetraene ketone is not 
stable. This instability is noted by the darkening of the 
reaction mixture with time from the original yellow-orange 
color of the pure C-18 tetraene ketone. Although the final 
product after two deuterium exchanges contains an acceptable 
level of deuterium (>95%), overall yields were low (40% 
after two exchanges). Analysis of the exchange by NMR or 
mass spectrometry showed that the degree of deuterium 
incorporation varied from one reaction to another. Every 
reaction must therefore be analyzed for the amount of 
deuterium Incorporated to determine whether additional 
exchange Is necessary. 
In Figure 3 the 60 MHz NMR spectra of 18,18,18-
2 Hg-all-trans tetraene ketone Is compared to the 
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non-deuceraced ketone. The loss of signal at 2.25 ppia 
indicates replacement of the alpha protons with deuterium. 
Figure 4 compares the 60MHz NMR spectra of retinal and 
20,20,20-^H2-retinal, in which the signal at 2.2 ppm 
is lost due to replacement of the protons on C-20. The mass 
spectra of the trideutero-retinal and of retinal are 
compared in Figure 5. The molecular ion of deuterated 
retinal is m/z 287, whereas that of retinal is m/z 284. 
Sizable quantities of trideutero retinal could not be 
synthesized by this route, largely because of low yields 
resulting from the formation of polymeric by-produccs in the 
two hydrolysis and dehydration reactions. 
The Synthesis of 20,20,20 Trideutero Retlnol Using the 
Wlttlg/Horner Reaction 
The advantages of this route of synthesis (Figure 6, 
are the preferential formation of the 
all-trans Isomer In the Wlttlg/Horner reactions 
(essentially 100% In the first reaction), the high yields 
(>60%) at each step, and the very low quantities of reaction 
side products. These advantages allow the crude product 
from one reaction to be used In succeeding reactions without 
further purification. The overall yield from beta-lonone 
for the sum of els and trans Isomers of H^-retlnyl 
acetate Is 15%. For the trans Isomer alone the yield Is 
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Figure 6. Synthesis of deuterated forms of vitamin A starting with beta-lonone 
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and the carbanlon of triethylphosphonoacetate. 20,20,20- H^-retlnolc 
acid 14,20,20,20-2H^-retinolc acid , 
12,14,20,20,20-2Hs-retlnyl acetate (R^=^H. R^=C^H^, R^=^Hj). 
lO.iq.lQ.IQ-^H^-rPtinvî acetate (R^-r^Hj. R^=^H) 
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approximately SX. The low yield (5X) in this case is 
outweighed by the elimination of tedious purification steps 
and by the use of large quantities of starting material that 
are easily handled in all the reactions. The major product 
losses were seen mainly during extractions and washing 
procedures. 
During the deuterium exchange reaction with the C-18 
tetraene ketone, a significant amount (40-60%) of the ketone 
was destroyed. Replacing dioxane with pyridine as the 
exchange solvent increased the yield from 40% to 62%, while 
varying the amount of solvent, quantity of base added, or 
using a single exchange reaction with a large amount of 
2 
H2O did not improve the yield. 
Nonetheless, a high degree of deuterium (>98% H^) can 
be incorporated into the remaining C-18 tetraene ketone 
(>95% (Figure 3). During the reaction of the 
triethylphosphonoacetate carbanion with the deuterated C-18 
ketone, however, approximately 40% of the deuterium in the 
trideuterated product was lost. Apparently, the phosphonate 
ion is a strong enough base to effect enolization of the 
ketone before condensation occurs (122). Thus, when the 
reaction is carried out as described here, with a three 
molar excess of the nondeuterated phosphonate in order to 
drive the reaction to completion, some of the deuterium in 
the methyl group of the ketone Is transferred to the 
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phosphonate. The enolic form of Che ketone is Chen free Co 
pick up a proton from a phosphonaCe carbanion ChaC does noc 
contain deuCerium, as shown in Figure 7. The presence of 
deuCerium in Che fourceen posicion of Che produce, echyl 
recinoace, confirms Chis mechanism. 
The Synthesis of 14.20.20.20 Tetradeucero Ratinyl 
Acetate by the WittiK/Horner Reaction 
In the synthesis scheme for 14,20,20,20-^H^ 
retinyl acetate, exchangeable protons on the phosphonate 
were completely replaced with deuterium (Figure 8C). This 
procedure not only eliminates deuterium loss from the 
ketone, but also yields a tetradeuterated retinoid. 
Figure 9B shows a 60 MHz NMR spectra of 14,20,20,20-
2 H^-retinoic acid ester. Normally found signals at 
2.25ppm and 5.8ppm are lost due to replacement of the four 
protons with deuterium. A 300 MHz NMR spectra (Figure 10) 
2 
of 14,20,20,20- H^-retinyl acetate shows loss of the 
signal at l.9ppm and S.6ppm normally found in nondeuterated 
retinyl acetate. 
The alpha protons of the phosphonate can be exchanged 
2 in HgO alone without addition of an organic 
solvent. Inasmuch as the phosphonate is water-soluble. 
Exchange occurs easily and yields a product with a high 
deuterium Incorporation. Figure 11 compares the 60 MHz NMR 
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Figure 7, Mechanism proposed by Johansen and Llaaen-Jensen 
(122) for the loss of the deuterium label due to 
enollzatlon of the C-18 tetraene ketone by the 
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Figure 8. The base catalyzed exchange reactions for the 
preparation of 13,13,13-trldeutero beta-lonone, 
18,18,18-trldeutero C-18 tetraene ketone, and 
dldeutero triethyIphosphonoacetate 
Figure 9. 60 MHz NMR spectra of A: 12,14,20,20,20-
2 (els + trans) retinoic ncld ethyl ester, B: 
14,20,20,20-^H^ all-trans retinoic acid ethyl 
ester and C: 20,20,20-^H2 all-trans retinoic 
acid ethyl ester. The arrows indicate absorption 
of the remaining protons of the C-20 methyl group 
and remaining appropriate ethylenic protons 
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Figure 10. 300 MHz ^H NMR spectra of A: all-trans 
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phosphonoacetate (B). The arrows Indicate where 
the alpha-protons of the phosphonate absorb 
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spectra of crlechyl phosphonoacetaCe and the deuterated 
species. By using deuterated trlethyl phosphonoacetate, 
incorporation into the fully deuterated retinoid Increased 
from 56% in the case of the ZO^ZOiZO-^Hg-retlnyl acetate to 
76% in the tetradeuterated retlnyl ester. Again the 
precursor materials are greater than 95% deuterated, but the 
products are only 76% tetradeuterated. The reduced 
incorporation of deuterium might bo the result of exchange 
under the basic reaction conditions with protons of a 
breakdown product of the precursor material over the course 
of the reaction. The identical reaction with beta-iononw 
showed excellent deuterium incorporation. 
NMR and mass spectral analysis of the deuterated 
phosphonate gave considerably different deuterium 
incorporation (>99% by NMR vs. 65% by MS). It should be 
noted that the alpha hydrogens are situated between a 
phosphono and carbonyl group, which makes these two protons 
extremely susceptible to exchange. Because the molecular 
ion was a minor species in MS analysis, deuterium 
incorporation was measured by analysis of a molecular 
fragment in the mass spectrum. Exchange within the ion 
source of the deuterated phosphonate or of a fragmentation 
product could account for this discrepancy. Thus, 
interpretation of the mass of fragments which contain labile 
deuterium atoms must be done with great care. 
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The Synthaala of 12,14,20,20.20 Pentadcutcro Retlnyl 
Acetate Via a Wittig/Horner Reaction 
A major advantage of this scheme is the elimination of 
the deuterium exchange reaction of the C-18 tetraene ketone. 
The latter step gives low yields and is associated with 
degradation of the ketone. By using perdeuteroacetone in 
the aldol condensation with beta-ionylidene acetaldehyde, 
the deuterium is directly incorporated into the ketone. 
Therefore, deuterium incorporation should be directly 
related to the deuterium content of the acetone. The C-13 
ketone produced by this procedure does have a high deuterium 
Incorporation, as seen In the 60 MHz NMR spectrum of the 
tetradeutero tetraene ketone (Figure 12). After the 
resultant condensation with dldeutero trlethyl 
phosphonoacetate, however, pentadeuterated retlnyl acetate 
amounted only to 40% of the total deuterated ester. Various 
amounts of the tetra, trl, dldeutero, and mono deuterated 
species were also present. Why the deuterium content of the 
pentadeuterated analog was lower than that of the 
14,20,20,20 tetradeuterated retlnyl acetate Is not readily 
apparent. Possible causes might be contamination with 
moisture or with other organic compounds containing labile 
protons. 
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The Synthesis of 10.19.19.19-Tetradeutero Rettnyl 
Acetate Via a Wittig/Horner Reaction 
Incorporating the deuterium with a base-catalyzed 
exchange into beta-ionone instead of into the C-18 tetraene 
ketone increased the deuterium content from 76% to >95% in 
2 
the final product, namely 10,19,19,19- H^-retinyl 
acetate. This increase in deuterium incorporation can be 
attributed to the greater stability of beta-ionone. The 
basic conditions of the deuterium exchange resulted in both 
high yields and In very little degradation of this more 
stable molecule. Similarly when beta-ionone is used in the 
Wlttlg/Horner reaction, both the breakdown of beta-ionone 
and the production of side products are minimized. These 
two considerations were deciding factors In developing this 
synthetic scheme. 
The 60 MHZ NMR spectra of the reaction intermediates 
2 for the synthesis of 10,19,19,19- H^-retlnyl acetate 
are shown In Figures 13 through 18. The l3-oethyl protons 
of beta-ionone (2.25ppm) have been fully replaced by 
deuterium during the exchange reaction (Figure 13). The NMR 
spectrum of the product of the Wlttlg/Horner reaction of 13-
2 Hg-beta-lonone with the dldeuterotrlethyl-phosphonoacetate 
Is shown In Figure 14. This 60 MHz spectrum shows loss of 
signals at 2.25ppm and 5.65ppm due to the deuterium 
2 
contributions of 13- H^-beta-lonone and dldeutero trlethyl 
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Figure 15. 60 MHz NMR spectra of 10,13,13,13-^H^ 
all-trans beta-tonylldeneethanol (A) and 
all-trans beta-tonylldeneethanol (B). The 
arrows indicate absorption of the protons on 
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Figure 16. 60 MHz NMR of 10,15,15,15-^H^ beta-
lonylldene acetaldehyde (A) and beta-
lonylldeneacetaldehyde (B). The arrows Indicate 
the absorption lost due to Introduction of 
deuterium at positions 10 and 15 
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Figure 17. 60 MHz NMR spectra of 10,17,17,17-^H^ 
all-trans C-18 tetraene ketone (A) and 
all-trans C-18 tetraene ketone (B). The 
arrows indicate absorption of the protons on 
carbons 10 and 17 
Figure 18. 60 MHz NMR of 10,19,19,all-
trans retinyl acetate (A), 14,20,20,20-^H^ 
all-trans retlnyl acetate (B), and 
all-trans retlnyl acetate (C). The arrows 
indicate the absorption lost due to the 
deuterium introduction 
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phosphonoacecace, respectively. The retention of these four 
deuteriums Is shown in the NMR spectrum of the 10,13,13,13-
^H^-beta-lonylldene ethanol (Figure 15), 10,15,15,15-^H^ 
beta-lonylldene acetaldehyde (Figure 16), 10,17,17,17-^H^ 
all-trans tetraone ketone (Figure 17), and In the desired 
2 product 10,19,19,19- H^-all-trans reclnyl acetate 
(Figure 18A) when compared to their non-deuterated 
analogues. A mass spectrum of the TMS derivative of 
10,19,19,19-^H^-all-trans retlnol is shown In 
Figure 19, compared to the spectrum of TMS-retlnol. The 
molecular ion Is enhanced relative to fragments of lower 
mass when low ionizing voltages are used. The Increase In 
the molecular ion m/z 358 to m/z 362 (M+4) is readily 
apparent. 
Analysis of Plasma Retlnol by HPLC 
The analysis of plasma vitamin A by HPLC is now 
commonplace (123,124). The conditions employed here were 
adjusted in order to monitor both vitamin A and vitamin E in 
the plasma. Retinyl acetate was used as the internal 
standard because it shows similar extraction and 
chromatographic characteristics as retlnol. Retlnol and 
retinyl acetate eluted at 3.4 and 5.1 minutes, respectively, 
in a reverse phase HPLC system utilizing methanol/water 
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Mass spectra of trimethyl silyl derivatives of 
retinol (A) and of 10,19,19,19-^H^ all-trans 
retlnol (B). Sample Introduction was via an 
OV-101 (3%) 3ft packed GC column run 
isothermally at 230®C (30ml/min He). Ionizing 
voltage of the Finnegan 4000 was 22eV 
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(95/5). A wavelength change from 325nm to 292nm (xmax for 
alpha-tocopherol) was performed 9-10 minutes after Injection 
In order to analyze tocopherol levels which eluted at 
approximately 15 minutes. Figure 20 shows a typical HPLC 
trace for the plasma analysis of vitamins A and E, in which 
retlnyl acetate was used as the internal standard. A 
standard curve for retlnol Is shown In Figure 21. Similar 
curves were generated for measuring tocopherol levels. An 
outline for the analysis of plasma vitamin A by HPLC and 
GC-MS is shown in Figure 22. 
Analysis of Retinol by GC-MS 
Standard solutions of TMS-retinol, prepared with 
TMSDEA, chromatographed cleanly on packed (3ft) or capillary 
columns (15M X 0.25mm) coated with a nonpolar liquid phase 
(OV-lOl or methyl silicon) (Figures 23 and 24). When the 
temperature was increased at a rate of 4-lO*C/min starting 
at 200*C, the best chromatographic results were obtained, 
including a clean separation from other components. 
Chromatographic conditions are summarized in Figure 25. 
Under optimal conditions linearity was achieved down to 20ng 
of TMS-retlnol by measuring m/z 255, a mass fragmentation 
product of TMS-retlnol (Mol Ut. 358) (Figure 26). 
When 5ul of solution containing a total of 
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Figure 20. HPLC trace of a a plasma extract analyzed for 
vitamin A and vitamin E. Retention times for 
retinol, retinyl acetate, and alpha-tocopherol 
were 3.41, 5.1, and 14.9 minutes, respectively 
(Whatman ODS-2, methanol/water 95/5, 2ml/min, 
325nm and 292nm) 
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Figure 21. A standard curve produced by Injecting 50ul (. » 
standard solutions of retlnol and retlnyl 
acetate. Chromatographic conditions as In 
Figure 20 
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OUTLINE OF PLASMA VITAMIN A ANALYSIS 
1. Take one ml plasma or serum 
2. Add 1ml 95% echanol (0.6ug/ml recinyl acetate, Internal 
standard) 
3. Vortex one minute 
4. Extract 2X2ml hoxanes (O.OIZBHT) 
5. Concentrate pooled extracts 
6. Dissolve residue in methanol 
7. Place an aliquot on HPLC (Whatman ODS-2, methanol/water 
95/5, 2ml/min, 325nm) 
9. Partition the collected retinol into hexane 
10. Dry the hexane extract over MgSO^ 
11. Concentrate and derivatize retinol 
12. Deactivate excess silyating reagent (methanol) 
13. Concentrate and analyze by GC-MS 
Figure 22. Analysis scheme for the quantitation of plasma 
vitamin A and determination of isotopic ratios 
by GC-MS 
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Figure 23. Isothermal packed column chromatography of a 5/1 
ratio of TMS-retlnol and ^H^-THS-retInol. 
Detection was» by a Flnaegan 4000 MS 
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Figure 24. Gas chrowatogram of a 1/3 mixture of TMS-retlnol and 
TMS-10,19,19,19-^H^-retlnol. Chromatography was performed on a 15M 
methyl silicon column (200-230®C at lO*C/mln, 2ml/mln He). 
Approximately 50ng total retinoid was Injected. The time scale Is 
staggered to show each peak clearly 
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GAS CHROMATOGRAPHIC CONDITIONS FOR TMS-RETINOL 
PACKED COLUMNS 
3fC X 2mm I.D. 
3% OV-101 or OV-17 
Injector 210*C 
Column 230*C Isocratic 
Carrier He # 30ml/mln 
CAPILLARY COLUMNS 
10-15 meter 
Injector 210*C 
Dry Column Injector 
Column 120°C one minute 
200-230®C at 4-lO®C/mln 
Carrier He @ 2ml/mln 
Figure 25. Summary of gas chromatographic conditions for 
trlmethyl sllyl retlnol 
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NO TMS-RSTIIMOt. 
Figure 26. Relationship o£ the area of the ai/z 255 fragment 
to ng TMS-retlnol Injected 
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approximately 66ng of both TMS-retinol and tetradeuterated 
TMS-retlnol in ratios of 1/10, 1/5, 1/1, 5/1, and 10/1 were 
analyzed at m/z 255 and m/z 259, the relative standard error 
increased as the ratio of 255/259 changed in either 
direction from H/D-l (Table 11). 
Table II. Mixture* of TMS-retlnol (66ng) containing 
mixtures of tetradeuterated and non-deuterated 
vitamin A were injected on a methyl silicon 
capillary column (15M). The relative standard 
error for measuring the area ratios at m/z 255 
and m/z 2^9 was calculated for five injections 
Raclo H/D at m/z 255/259 relative Mtd wrror 
At a unit ratio, the relative standard error was 2.9% 
for five measurements, but Increased to 8.1% for a I/IO 
ratio and 7.9% for a lO/l ratio. These measurements, done 
on a I5m DB-5 capillary column with a dry column Injector, 
show that Isotoplc ratios can be measured at fairly low 
absolute levels. As isotoplc ratios depart from unity, 
however, the accuracy of the measurement decreases at a 
similar rate In both directions. 
The sensitivity of the analysis Is Increased by the 
1/10 
1/5 
1/1 
5/1 
10/1 
8.1% 
6.7% 
2.9% 
4.5% 
7.9% 
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prior injection of large (2-lOug) amounts of TMS-retinol, 
presumably by deactivation of reactive sites in the column, 
as Dunagin and Olson previously indicated with the use of 
beta-carotene (125). Degradation was expressed by leading 
edges on the TMS-retinol peak and by the lack of peak 
symmetry. This asymmetry was eliminated, in the case of 
standard solutions, by adjusting the temperature program, 
carrier gas flow rate and the column length to give shorter 
retention times for TMS-retinol. Silylatlng all exposed 
glass In the chromatographic system also proved to be 
important. Figure 27 shows the effects of various 
temperature programs on the peak shape and retention of 
TMS-retinol. 
Initial work with six-foot packed columns showed poor 
peak shape with evidence, in the form of multiple peaks, of 
TMS-retinol degradation. Shorter columns (3ft) alleviated 
much of this problem. This improvement can be attributed to 
fewer active sites in a shorter column and to shorter 
retention times. By using 30-40ml/min flow rates, retention 
times were also reduced. 
The TMS-retinol ether, although more stable than the 
free alcohol, retains the same sensitivity to light, 
Isomerization, oxidation and thermal lability. Stock 
solutions and especially dilute solutions of TMS-retlnol 
showed increasing degrees of isomerization upon standing or 
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Figure 27. The effect of varying the column temperature 
program and the flow rate on the elution of 
TMS-retlnol. Scan number Is Indicated on the 
K - a x i  s  
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during manipulation (e.g., evaporation, transfer, etc.). 
Vitamin A is susceptible to heat, light and oxidative 
conditions. Vitamin A's sensitivity to oxidation has been 
noted as one of its main characteristics (14). High 
chromatographic temperatures only serve to exacerbate 
vitamin A's instability. The vitamin's light sensitivity, 
on the other hand, can be controlled. All procedures In 
this study were carried out under Westinghouse F-40 gold 
fluorescent tubes, which emit light above SOOnm only. 
Absorption by vitamin A at these wavelengths is minimal, and 
vitamin A exposed to these lamps has been shown not to 
undergo isomerization, as previously reported (126). 
Although standard solutions of TMS-retinol can be 
measured by GC-MS to low levels (20 ng) (Figure 26), and the 
ratios of standard mixtures of tetradeuterated and 
nonlabeled vitamin A have been successfully measured (Table 
II and Figure 28), attempts to derivatlze retinol in a 
purified plasma extract have not been successful. 
In attempts to resolve this problem, retinol in amounts 
similar to those recovered from plasma were used to test the 
derivatlzatlon procedure. Generally these samples were 
concentrated solutions containing approximately 0.1 mg/ml 
retinol. At this concentration 10 ul of solution could be 
transferred to a 0.3 ml Reactl-Vlal and treated the same as 
a purified plasma sample ready for derivatlzatlon. 
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Figure 28. Log/log plot of measured H/D ratios versus 
calculated H/D ratios measured at mlz 255. 
Error bars represent +/- standard deviation for 
five values 
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Several experiments were carried out to verify that 
retinol from plasma could be efficiently extracted and 
carried through to the dérivâtization stage. 
Table 111. The efficiency o i  extraction of retinol by 
hexane from a 95/5 methanol/water mixture, the 
HPLC solvent used for plasma retinol 
purification, after addition of different 
quantities of water 
PARTITIONING OF RETINOL BETWEEN HEXANE AND 
METHANOL/WATER 
ml water added Hexane MeOH/Water 
0.0 0.097 0.192 
0.092 0.184 
0.5 0.303 0.047 
0.303 0.046 
1.0 0.407 0.010 
0.419 0.003 
After the addition of 1ml of hexane and 1ml of water to 
1ml of a methanol/water 95/5 solution that contained 
retinol, retinol was almost entirely found in the hexane 
phase (Table III). In practice a twofold excess of hexane 
was used to maximize extraction efficiency and to minimize 
manipulative losses. 
The hexane layer used to extract retinol from the HPLC 
solvent is next dried with magnesium sulfate powder. To 
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determine if any retinol is lost during drying, Iml of a 
hexane solution of retinol at a concentration of 2ug/ml was 
vortexed with 100-200mg MgSO^. Decanting the hexane 
layer after centrifugation and analysis by UV absorption 
showed that the drying of a hexane solution of retinol, even 
at low concentrations, does not result in absorption or 
degradative loss of the retinoid. 
The samples were dried because both silyating reagents 
as well as the TMS derivatives are sensitive to moisture. 
In the presence of water, hexamethyldisiloxane is formed. 
Repeated injection of samples containing hexamethyl­
disiloxane caused rapid and significant decreases in the 
peak resolution and shape of TMS-retinol during 
chromatography. 
TMS-retinol standards injected after samples that 
contained hexamethyldisiloxane also failed to chromatograph. 
This same effect was also found with BSA and Its reaction 
byproducts, N-(trlmethylsllyl)acetamide (mp 46-49"C, bp 
84"C/18mmHg) and acetamide (bp 221"C). Satisfactory 
chromatographic results could be obtained only after 
elevating the oven temperature for several hours which 
removed these high boiling compounds. 
The dried (MgSO^) hexane solution containing the 
retinol Is next decanted, after centrifugation. Into a 12 X 
75 mm culture tube. The tube Is put In a 45"C heating block 
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and Che hexane Is evaporated under a stream of argon to n 
volume of approximately 100-I50ul. The latter is 
transferred into a 0.3 ml Reacti-Vial and taken almost to 
dryness under a stream of argon. The sample is then ready 
for derivatization. Comparison of lug amounts of retinol 
directly injected onto a straight phase HPLC system 
(u-Porasil, 25% ethylacotate/hexane, 325nm) with an 
equivalent amount dried from 1ml hexane and taken up in lOul 
of hexane showed consistent recoveries of 50-801 (Table U 
Table IV. Retinol (lug) in 1ml hexane with or wlchour n j 
BHT was concentrated under a stream of argon ar 
taken up in 10 ul hexane. Comparison was made 
with an equivalent amount of retinol Injected 
directly on a straight phase HPLC system 
(u-Porasll, ethylacetate/hexane, 325nm, 2ml/mln) 
RECOVERY OF RETINOL DURING CONCENTRATION AtlD 
DISSOLVING IN HEXANE 
No addition 0.01% BHT lOOul Rinse 
60-71% 59-79% 55-78% 
The use of antioxidants such as butylated hydroxy-
toluene failed to Improve this recovery. This loss Is most 
likely the result of surface adsorption during the drying 
process. Rinsing the glass surfaces with hexane, however, 
did not Improve the recovery (Table IV). 
In experiments carried out to determine the stability 
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and recovery of TMS-retinol under the conditions used for 
evaporation, Sing to 1024ng in I20ul hexane was evaporated 
to approximately 2ul in a 0.3ml vial, and the contents were 
taken up in 60ul hexane. This sample was then injected onto 
a straight phase HPLC system (u-Porasil, 0.25% ethyl-
acetate/hexane). Recoveries were greater than 94% in all 
cases, and chromatograms showed no qualitative differences 
(Table V). 
Table V. TMS-retinol In I20ul hexane is dried to 
approximately 2ul in a conical 0.3ml Reactl-Vial. 
The contents are then rinsed with 60ul hexane and 
injected onto a HPLC column (u-Porasil, 0.25% 
ethylacetate/hexane, 2ml/min, 325nm). The last 
sample shows recovery of TMS-retinol in the 
presence of TMSDEA 
RECOVERY OF TMS-RETINOL DURING CONCENTRATION 
AND DISSOLVING IN HEXANE 
ng TMS-retinol % Recovery 
1024 
512 
256 
128 
51.2 
128 + 8ul TMSDEA 
94.3% 
97.0% 
101.6% 
98.3% 
101.6% 
103.4% 
The addition of 8 ul TMSDEA to these solutions showed 
no appreciable effect on the recovery (Table V). Thus the 
presence of the derlvatizing reagent TMSDEA has no effect on 
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Che stability o£ TMS-recinol. 
Because there is a volume limit on the injection of 
solvent in gas chromatography, volumes are generally less 
than 10 ul and are most commonly in the 0.5 to I ul range. 
When capillary columns are used, the volume injected becomes 
increasingly critical because of the smaller column 
dimensions and loading capacities. These volume 
requirements and the need to inject as much of the retinol 
derivative as possible imposes the requirement that the 
derivatizing agent be easily evaporated. The initial 
reagent used for silylation was fl,0-bls(trlmechylstlyO-
acetamide (BSA). Although BSA was an efficient silylating 
reagent, it leaves involatile reaction aide products. 
Indeed the reagent itself Is not very volatile, having a 
boiling point of 7l-73®C/35mmHg. Although BSA gives high 
yields of TMS-retlnol when derivatizing at the ng level, it 
Is not easily removed. Furthermore its presence or the 
presence of reaction by-products destroys the ability of 
packed and capillary columns to separate TMS-retlnol. In 
essence, the same problems are encountered as with 
hexamethyIdls iloxane. 
Standards of t-butyldimethylsllylretlnol can also be 
prepared from t-butyldimethysllyllmldazoledlmethyformamlde 
and retinol. This derivative, however, showed longer 
retention times than TMS-retlnol and was not considered 
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further. 
The fluorlnaced analogue of BSA, N,0-bls (trimethyl-
sllyl) trlfluoro acetamide was Cried, inasmuch as its by­
products, monotrimethylsilyltrifluoroacetamide and 
trifluoracetamide, are more volatile than those produced 
from BSA. However this reagent, when used in a manner 
identical to that of BSA, destroyed vitamin A. 
Trimethylchlorosilane (TMCS) (Figure IE) in neat 
preparations destroyed vitamin A. When trimethylchlorosilane 
was used in conjunction with hexamethyldisilazane (Figure 
IF) in proportions of I to I and I to 2, respectively, 
TMS-retinol was formed (127). As measured by HPLC (0.25% 
ethylacetate/hexane, u-Porasil), the yield of TMS-retinol 
was lower with these reagents than with N-trimethylsilyl-
diethylamine (TMSDEA). When this mixture was used, a solid 
precipitate of ammonium chloride also formed as a by­
product, which interfered with derivative recovery. 
Tri-Sll (Pierce Chemical Co., Rockford, III.) a 
commercially prepared reagent containing hexamethyl-
disllazane (HMDS) and trimethylchlorosilane In pyridine, was 
also tested. This reagent gave a yield of TMS-retlnol 
similar to that of mixtures of HMDS and TMCS, but also gave 
a precipitate of NH^Cl. 
Trlmethylsllyldlethylamlne (TMSDEA) proved to be the 
best derlvatlzlng agent tried. It has a higher volatility 
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(bp 126*C/738mmHg) Chan any reagent which would derivative 
retinol without destroying It. It has the added advantage 
that the by-product, dlethylamlne (bp 55*C), Is also 
volatile. Complete derlvatlzatlon oE standards occurs 
within five minutes. Quenching the reaction by the addition 
of methanol, at a ratio of two volumes TMSOEA to one volume 
MeOK, showed a three-fold Increase In the yield of 
TMS-retlnol over derlvatlzatlon reaction mixtures where 
TMSDEA was dried down alone. Addition of methanol produces 
methoxytrlmethylsllane (bp 57-58*C) and additional diethyl-
amine, both of which are readily evaporated. The use of 
lOul of TMSDEA, followed by 5ul methanol after 1-2 minutes, 
showed better yields of TMS-retlnol than the use of any 
other volumes, concentrations or solvent mixtures tested. 
The peak area generated by injecting 300ng of standard 
TMS-retlnol in a capillary column via a dry column injector 
and analyzed with a FID was compared to 300ng retinol 
evaporated from hexane (66ul) under a stream of nitrogen and 
derlvatized by lOul TMSDEA followed by 5ul methanol. The 
latter solution was evaporated under a stream of Ng, and 
the residue was taken up in 20ul hexane for GC injection. 
Injection of this sample showed yields of 41-52% of the 
standard sample. 300ng of standard TMS-retlnol that was 
treated Identically showed recoveries by a FID of 46-54%. 
Thus, it appears that derlvatlzatlon of the alcohol is 
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complete but that a 40-50% loss occurs during the recovery 
procedure. 
To improve the recovery and to inhibit destruction, 
various facets of the recovery procedure were investigated. 
The effects of several carriers and antioxidants were 
tested, including the following: beta-carotene, BHT, 
alpha-tocopherol, beta-ionylideneethanol and the latter's 
TMS derivative. Various solvents for delivery and recovery 
of retinol samples were evaluated, including ethylacetate, 
CH^Clg, CHClj, acetonitrile, heptane, pentane, 
hexane and pyridine. The gases used for evaporation, 
including He, Ar and ^2, were compared. The use of low 
heat without a gas stream, and centrifugal vacuum 
evaporation (Speed VAC Concentrator) were evaluated. 
Finally, the effects of using plastic containers in place of 
silylated glassware were examined. None of these variations 
Improved the recovery beyond that given by the initially 
outlined procedure. 
The conversion of retinol to anhydroretinol in the 
presence of HCl was also evaluated. Standard solutions of 
anhydroretinol showed a series of peaks upon GC analysis, 
indicating that a multitude of breakdown and isomerlzatlon 
reactions were occurring. This observation agrees with 
previous reports that anhydroretinol is not an appropriate 
form for GC analysis (128). 
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In summary, purified vitamin A from plasma can be 
extracted, dried (MgSO^), and concentrated with a 
minimum of 50% yield. Furthermore, retlnol standards can be 
derivatized and introduced into the GC-MS with a yield of 
41-52%. The measurement of standard solutions of 
nondeuterated and tetradeuterated retlnol can also be 
measured at levels of 60-100ng of material injected. On the 
basis of these yield values, the original amount of retlnol 
needed to give an acceptable response in GC-MS is 487ng of 
retlnol. This amount should be easily obtainable from 2ml 
plasma with a concentration of 0.3ug/ml retlnol. In 
practice, however, every attempt to carry a sample through 
the process from extraction of plasma retlnol to 
dérivâtization and GC-MS analysis resulted in the detection 
of little or no TMS-retinol. 
The fragmentation pattern of TMS-retinol can be varied 
by a number of factors. Among these factors are the source 
configuration and the ionizing voltage. The ion source Is 
the site of molecular fragmentation, where a stream of high 
voltage electrons impinging on a sample cause it to break 
into charged fragments which are dependent upon the 
molecular structure of the compound. This series of 
fragments, displayed in an appropriate way, gives rise to a 
mass spectrum unique for each compound. Because the degree 
of fragmentation is dependent upon the energy of the 
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ionizing electrons, a standard o£ 70 eV is generally used In 
order to compare results from different instruments. The 
importance of instrument design on the relative amount oE 
the molecular ion obtained and on the fragmentation pattern 
of TMS-retlnol is clearly shown In Figure 29. Low ionizing 
voltages tend not to have enough energy to form the low 
molecular weight fragments. The relative amounts of the 
molecular ion and higher molecular weight Ions are enhanced 
at low voltages (Figure 30). 
The total ton currents for the molecular Ion of 
TMS-retlnol (m/z 358) and for a major fragment (ro/z 255) are 
plotted versus the ionizing voltage in Figure 31. It is 
clear from Figure 31 that the ion currents for the selected 
masses Increase with the ionizing voltage up to a plateau, 
which for TMS-retlnol was found between 70 and 90 eV. 
The ion selected for measuring isotopic ratios of 
TMS-retlnol is dependent upon the Instrument used. Figure 
29 shows the mass spectrum of TMS-retlnol on an Extranuclear 
SpectrEl (A) and a Finnegan 4000 mass spectrometer (B) at 
low ionizing voltages. The Extranuclear Instrument shows a 
fragment at m/z 255 (M-CHg-OTMS) and no m/z 268 
fragment, which Is characteristic of anhydroretinol, the 
dehydration product of retinol. 
In contrast, the Finnegan mass spectrometer shows m/z 
268 as the base peak (Figure 29). This variation in the MS 
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Figure 29. Comparison of mass spectra of all-trans 
trimethyl silyl retinol on an Extranuclear 
SpectrEl MS system at 20eV (A) and a Finnegan 
4000 MS at 17 eV ionizing voltage (B) 
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Figure 30. Ion current of TMS-retlnol mass fragment m/z 253 
relative to the total Ion Intensity plotted as a 
function of Ionizing voltage. The data were 
collected on an Extranuclear Spectral MS systen 
with a ISM methyl silicon capillary column 
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Figure 31. Ion current plotted as a function of the Ionizer 
Ionizing voltage for m/z 255, m/z 358, and total 
Ion Intensity of TMS-retlnol 
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fragmentation pattern is most likely the result of 
differences in the configuration of the ion source found in 
the two instruments. 
Perfluorotributylamine (mol wt 602) (PFT) was used as 
the calibration gas in mass spectrometry. All lenses and 
ion currents were maximized against PFT fragments m/z 219 
and m/z 264, which were close to the retinoid fragments of 
interest (m/z 255 and m/z 268). 
The mass spectra of TMS-retinol and of 10,19,19,19-
2 H^-TMS-retinol, scanning from 240-380 amu on the 
ExtraNuclear instrument, are shown in Figure 32. The m/z 
255 fragment is the largest of the high molecular weight 
fragments found, and, as noted by the Increase In the mass 
by M+4 in the tetradeuterated analog, still retalne all of 
the deuterium label. The negligible contributions at m/z 
259 in the non-deuterated vitamin A and at m/z 255 In the 
tetradeuterated material show that these MS fragments from 
appropriately deuterated vitamin A are suitable for use In 
an Isotope dilution assay. 
Figure 32. Maes spectra of trlmethyl sllyl all-tran# 
retinol (A) and trlmethylsllyl-10,19,19, 
all-trans retinol (B). Samples were 
introduced via a 15M SE-30 capillary column Into 
an Extranuclear SpectrEl Mass spectrometer with 
an ionizing voltage of 70eV 
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DISCUSSION 
The directed aldol condensation described by Wittig and 
Geissler (104) was used by Tanis £t £l. for the 
preparation of dimethyl substituted retinaldehyde (117). In 
the directed aldol condensation described, metalated 
propylidene cyclohexylamine was reacted In two different 
steps with the methyl ketones, beta-ionon# and all-trans 
C-18 tetraene ketone, to synthesize all-trans 10,14 
dimethyl retinaldehyde in 2.2% yield after purification. 
This same reaction can be used to synthesize unsubstituted 
retinaldehyde by using ethylidene cyclohexylamine in place 
of propylidene cyclohexylamine. 
In this scheme, the three protons on the alpha-methyl 
groups of the methyl ketones can be replaced by base 
catalyzed exchange with deuterium oxide. The production of 
beta-ionylidene acetaldehyde by this method gave a 30% yield 
from beta-ionone consisting of approximately 18% all-trans 
and 12% 9-cis triene aldehyde. Tanis et al. (117) 
reported higher yields (50%) of lO-methyl beta-ionylidene 
acetaldehyde, but the major product was the cis isomer (36% 
cis + 14% all-trans). The presence of the lO-methyl group 
in the condensation product had two major effects: I) the 
cis isomer was favored over the all-trans. which might be 
considered as undesirable, and 2) the yield was higher. 
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i.e., 50% vs. 30%. The greater overall yield of 10-methyl 
beta-ionylidene acetaldehyde may be the result of the 
greater stability of the methyl substituted compound to 
iodine dehydration. 
Condensation of beta-ionylidene acetaldehyde or its 
methylated analogue with acetone gave similar yields (ca. 
80%) of the lO-methyl substituted C-18 tetraene ketone and 
of the unsubstituted product. The final condensation 
between ethylidene or propylidene cyclohexylamine with the 
C-18 tetraene ketone, however, gave recoveries of 1% for 
retinal compared with approximately 20% for the 10,14 
dimethyl analogue. In both cases the beta-hydroxy adduct 
formed in significant amounts. The iodine dehydration of 
hydroxy retinal, in contrast to the dimethyl analogue, 
however, proved to be very difficult. All attempts to 
accomplish this dehydration yielded little or no retinal and 
were accompanied by the appearance of a tar-llke polymer. 
Use of other dehydrating reagents, such as paratoluene 
sulfonic acid, failed to dehydrate the beta-hydroxy adduct. 
In contrast, the yield of the 10,14 dimethyl substituted 
retinal (36% cis + trans) from the tetraene ketone was 
satisfactory. Thus, the methyl groups may well stabilize 
the beta-hydroxy adduct, enhance the dehydration reaction, 
and stabilize the final product in the presence of iodine. 
Because of the difficulties outlined above, the 
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WlCClg/Horner reaction was explored as an alternate route to 
synthesize deuterium labeled vitamin A. The procedure 
seemed attractive because alpha,beta-unsaturated 
Intermediates were produced without destructive Iodine 
dehydration and mild reaction conditions were employed. 
Indeed, the Wlttlg/Horner reaction did produce the desired 
products In high yield and predominantly formed the 
all'trana isomers. Furthermore, the products were 
easily separated from the phosphorus-containing side 
products. 
The first reaction of beta-lonone with 
trlethylphosphonoacetate gave all-trans beta-lonylldene 
acetate In 92% yield. This product was pure enough to be 
reduced (LIALH^) directly to the alcohol and oxidized 
(MnOg) to beta-lonylldene acetaldehyde. The yield of 
the all-trans Isomer (78%) Is fourfold greater than that 
obtained by the directed aldol condensation. 
The disadvantage of a three step synthesis, i.e., 
condensation, reduction and oxidation, in the case of the 
Wittig/Horner reaction is outweighed by the greater overall 
yield and the higher purity of the products. Use of a two 
or three fold excess of the phosphonate carbanion left 
virtually no unreacted beta-ionone. The excess carbanion is 
deactivated by water and removed in subsequent extraction. 
Reduction with lithium aluminum hydride (LAH) was straight 
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forward, with the exception that the reduction proceeded 
more smoothly and in higher yield if the acid ester was 
added to a cooled (-70*C) LAH solution. LAH reduction is 
normally performed at room temperature. 
Oxidation of vitamin A alcohols to aldehydes by 
Mn02 is a well-known reaction (129,130). The reaction 
properties of activated Mn02 are greatly dependent, 
however, on the method of preparation (131). Consistent 
results were obtained with a manganese dioxide preparation 
from the Aldrich Chem. Co. after experimenting with other 
commercial preparations and with preparations prepared In 
the laboratory by the method of Attenburrow et al. 
(132). Complete oxidation of beta-lonylideneethanol to 
beta-ionylidene acetaldehyde was found using a one to five 
ratio (wt/wt) of the alcohol to manganese dioxide. 
Preparation of the C-18 tetraeneketone from the 
condensation of acetone with beta-lonylldene acetaldehyde 
was identical to that used in the directed aldol 
condensation. In both cases, the ketone was formed in 
80-90% yield. The final Wlttlg/Horner reaction, in which 
retlnolc acid ethyl ester Is formed from the C-18 tetraene 
ketone and trlethylphosphonocarbanlon, gave the all-trans 
isomer in 40% yield, with a total yield of 65% (els + 
trans). 
The addition of the last two-carbon unit to the C-18 
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cecraene ketone was less complete than the Identical 
reaction with beta-lonone. This was seen in the lower yield 
(65% vs. 92%) and the presence of unreacted ketone In the 
final reaction. Using excess trlethylphosphonoacetate 
carbanlon or repeating the reaction on the crude product, 
which had been quenched, extracted, and dried, helped to 
Increase the yield of this step. 
The form of vitamin A used for isotope dilution studies 
is either the free alcohol or ester (18,92). Reduction of 
the acid ester to the free alcohol and its reesterlflcatlon 
were accomplished by LAH and acetic anhydride in pyridine, 
respectively. Reduction of the acid ester was performed at 
-70®C, which gave retinol in 85% yield. Acylatlon with 
acetic anhydride In pyridine afforded the acetate ester in 
60% yield. 
Deuterium incorporation was Initially done at the level 
of the C-18 tetraene ketone. According to general 
principles, the labeled atoms should be incorporated near 
the end of the synthesis scheme. Base-catalyzed exchange of 
the tetraene ketone proved to be destructive, however, as 
indicated by the darkening of the initial clear yellow 
solution to a dark red and by the low yield of the 
deuterated product after purification. Despite the low 
recoveries, a trldeuterated C-18 tetraene ketone with 
significant deuterium content was produced (>95% H^). 
I l l  
Higher yields were obtained when the exchange was done in 
pyridine (62%) than in dioxane (40%). 
Notwithstanding the high deuterium content of the 
tetraene ketone, the final product, a 20,20,20 trideuterated 
retinoid never contained more than 80% retention of the 
label, as shown in Table I. Johansen and Liaaen-Jensen 
(122) proposed a mechanism for this exchange reaction 
(Figure 7), namely that the phosphonate carbanion is a 
strong enough base to effect enolization of the ketone and 
therefore to allow loss of the deuterium from the 
alpha-methyl group. To avoid the exchange with phosphonate 
hydrogen atoms, deuteration of the phosphonate itself was 
explored. Triethylphosphonoacetate was dissolved directly 
2 in the exchange medium of deuterium oxide and NaO H. An 
apparent discrepancy arose, however, when evaluating the 
level of incorporation. Spectra obtained from NMR analysis 
indicated >98% replacement of hydrogen with deuterium, while 
analysis by gas chromacography coupled to mass spectrometry 
(GC-MS), showed only 65% of the product with the mass 
Increased by 2 amu. In GC-MS, however, the incorporation of 
deuterium In the phosphonate was evaluated from a mass 
fragment. Inasmuch as the molecular ion peak was too small 
to measure. Deuteriums situated between phosphono and 
carbonyl groups are extremely susceptible to exchange, and 
thus loss of the deuterium during mass spectral analysis 
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could result from exchange either during gas chromatography 
or during fragmentation o£ the molecule. Synthesis of the 
10,19,19,19 tetradeuterated retinoid with a deuterium 
Incorporation of 98% was formed by use of the deuterated 
phosphonate, the deuterium content of the phosphonate Is 
clearly reflected more accurately by NMR analysis. Thus, 
care must be exercised In Interpreting the results of GC-MS 
analysis, when unstable labeled compounds are being studied. 
Reaction of the deuterated phosphonate and the 
IS.lSjlS-^Hj C-18 tetraene ketone afforded the C-20 
retinoid with BOX of the deuterium content of the starting 
material. Efforts to improve the extent of incorporation 
failed. The loss of deuterium is most likely the result of 
exchange with protons made available during the course of 
the reaction by the breakdown of reactants or products. 
Perdeutero acetone could be substituted for acetone in 
the base catalyzed condensation with beta-ionylidene 
acetaldehyde. Production of 12,18,18,18 ^ H^-C-18 
tetraene ketone and its reaction with the dideuterated 
triethylphosphonocarbanion gave a pentadeuterated retinolc 
acid. Only 40% of the retinolc acid ester produced, 
however, contained five deuterium atoms. 
Increasing the side chain length of the intermediate 
appears to be associated both with instability and with a 
less efficient incorporation of deuterium. When beta-ionone 
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was used as a substrate Eor deuterium incorporation, no 
evidence was found of breakdown or of side reactions. After 
two exchanges with deuterium oxide, the deuterium content oE 
the l3-methyl group was shown to be >98% A 
Wittig/Horner reaction between this trideuterated 
beta-ionone and the dideutero triethylphosphonoacetate 
carbanion ultimately yielded the desired 10,19,19,19-^H^ 
2 
retlnyl acetate with a deuterium content of 98% K^. 
The incorporation of deuterium at the level of 
beta-ionone was higher than that seen when the deuterium waa 
Introduced later in the reaction scheme. This higher level 
of incorporation Is attributed to the greater stability of 
the substrate to the conditions both of the exchange 
reaction and of the subsequent Wittig/Horner reaction. 
In the analysis of plasma vitamin A by GC-MS, some 
method of sample preparation is required to free the vitamin 
A alcohol from the complex matrix of phospholipids and 
triglycerides which are co-extracted with retlnol from 
plasma. This separation was readily accomplished by 
reverse-phase high pressure liquid chromatography (HPLC). 
By using a highly efficient Whatman Partisll ODS-2 column 
and a methanol/water (95/5, 2ml/min) solvent system, retlnol 
eluted at 3.4 minutes, the internal standard retlnyl acetate 
at 5.1 minutes and alpha-tocopherol at 14.1 minutes. 
Tocopherol levels can be measured by switching the detection 
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wavelength from 325nm to 292nm after the elutlon of retlnyl 
acetate is complete. 
HPLC of the plasma extract provided for purification of 
the plasma retinol and quantitation in a single step. Peak 
height or area ratios of retinol to internal standard were 
linear to 50ng/ml. 
The use of retinyl acetate as an internal standard has 
been previously described (123,124,133). Retinyl acetate Is 
intermediate in polarity between retinol and the long-chain 
retinyl esters, separates easily from retinol on reverse 
phase HPLC, has identical absorption maximum and Is not 
found in biological samples (133). Oriskell et al. 
found that the use of one internal standard was equal In 
precision and acccuracy to two, one for each vitamin (123). 
Mass spectral analysis of compounds requires that they 
be Introduced into an ionizing source where pressures are 
generally In the order of lO'^-lO"^ Torr. To maintain 
the ionizer at these pressures, special methods have been 
developed for sample introduction. When neat samples are 
available, introduction by a solids probe may be used. The 
sample is Introduced through a vacuum lock and vaporized 
from a small glass vial Inserted Into the Ionizer. This 
method, which requires 2-lOul of neat material, is useful 
when dealing with significant quantities of material. 
A second method Is by coupling the effluent of a gas 
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chromacographic column Co Che ionizer. Where packed columns 
are uCilized, Che gas effluenC from Che column is usually 
30"40ml/min. MosC mass specCromeCers will accommodace 
inpuCs of only O.lSml/min. Consequencly, some means of 
separacing mosC of che carrier gas from Che sample muse be 
provided. A number of useful incerfaces have been designed 
for Chis purpose. Membranes highly porous Co helium but 
much less so Co Che sample can be used. Thus, Che bulk of 
Che helium can be pumped away by a separace pump whereas 
mosC of Che sample is Cransferred Co Che source. Transfer 
efficiencies with chis mechod range from 10-50% (134). 
AnoCher Cype of separacor is Che JeC separaCor, where 
Che GC effluenC passes chrough a capillary abuccing a second 
capillary of slighcly larger dimensions several micromecers 
from Che firsc. A high vacuum placed around chis conneccion 
pumps away a majoricy of Che low molecular weighc carrier 
gas while heavier compounds pass inco che second capillary 
connected to the mass spectrometer source. 
Capillary columns with typical flow rates of 2ml/min 
can be connected directly to the Ionizer of the mass 
spectrometer. If sufficient pumping capacity Is available. 
Newer pumping systems provide this capacity. Gas 
chromatography coupled to mass spectrometry has the added 
advantage that the sample Is Introduced In a fairly pure 
state, subject to the limitations of the gas chromatographic 
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state, subject to the limitations of the gas chromatographic 
separation. 
Unfortunately retinoids tend to be unstable during 
gas-liquid chromatography (GLC) (125,135-139). Both 
destruction and isomerization of the retinoids occurs during 
GLC treatment. Anhydroretinol, a dehydration product of 
retinoX which is more stable than retinol during GLC, is 
nonetheless extensively isomerized to a mixture of cU and 
trans isomers during separation (137,140). 
In order to increase the stability of retinol for 
GLC-MS analysis, it was necessary to form Its trimethyl 
silyl ether. A variety of reagents used for the conversion 
of alcohols to their trimethylsilyl ethers are commercially 
available. Several of these have been evaluated for their 
efficiency in converting retinol to the TMS-ether. Vecchi 
et al. (136,137) used N,0-bis(trimethylsilyl) 
acetamide (BSA) as both a derivatizing reagent for vitamin A 
alcohol and for column deactivation. Repeated injections of 
the silylating reagent every 20min over a period of several 
days improved the yield of chromatographed retinoids. 
Horning et al. (141) also found BSA to be a better 
silylating reagent than combinations of hexamethyldisilazane 
(HMDS) and trimethylchlorosilane (TMCS), which were found to 
be very destructive (141). The present study confirms these 
observations. Although BSA gave good yields of TMS-retlnol 
U7 
in Che milligram range, its use for derivatizing retinol in 
the nanogram range was less satisfactory. After repeated 
use deterioration was noted in column performance and in the 
peak area and peak shape of TMS-retinol. This deterioration 
was also seen when HMDS, which forms in the reaction of 
silylating reagents with water, was injected onto the GLC 
column. The reason for this deterioration is not known. 
Column performance could only be restored after baking the 
column at elevated temperatures for several hours, 
presumably to elute or destroy the interfering material. 
The ability to prepare usable standards with BSA can be 
attributed to the dilution which occurs before use. 
Column performance was much Improved when trlmethyl 
sllyl dlethylamlne (TMSDEA) was used. Of those reagents 
which were not destructive, TMSDEA has the highest 
volatility (bp 126"C/738mmHg). The by-product of this 
silylating reaction Is dlethylamlne, which is also volatile 
(bp 55"C). The formation of TMS-retlnol from TMSDEA and 
anhydrous retinol (O-lOug) was essentially quantitative, as 
measured by HPLC analysis (u-Porasll, 0.5% ethyl 
acetate/hexane). For analysis by GLC, the volumes of 
Injected samples should be as small as possible. Rather 
than drying TMSDEA directly, the prior addition of methanol 
(2:1, TMSDEA:MeOH) resulted In the production of methoxy 
trlmethylsllane (bp 57-58"C), which easily evaporated 
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together with dlethylamlne (bp 55"C). The removal of excess 
TMSDEA by reaction with methanol showed a threefold Increase 
In the recovery of TMS-retlnol during concentration when 
compared to the TMSDEA/TMS-retlnol reaction mixtures that 
were dried and analyzed by GLC without prior reaction. 
When 300ng retlnol In 66ul hexane are treated with 
TMSDEA, the recovery of the derlvatlzed TMS-retlnol In 2Qul 
hexane, a sample small enough to be Injected In the 
dry-column Injector, was 40-50%. TMS-retlnol (300ng) In 
66ul hexane showed Identical recoveries when subjected to 
the same procedure (analysis done with a FID detector and a 
15M DB-5 capillary column). Use of other solvents, 
sllanlzed vials, other gases, different temperatures and 
various antioxidants failed to Improve this recovery. This 
recovery was much lower than that obtained by HPLC analysis 
(0.25% ethylacetate/hexane, u-porasll column), where 
TMS-retlnol concentrated with or without the presence of 
TMSDEA showed almost quantitative recoveries (Table V). 
This discrepancy is related to the method of analysis. HPLC 
is noted for its nondestructive nature, whereas the 
conditions used for GLC are not conducive to the stability 
of retinoids. 
The isolation of plasma retlnol, after partitioning 
between hexanes and an HPLC solvent fraction of 
methanol/water and subsequent drying, was found to be nearly 
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quancicatlve. The recovery of this anhydrous reclnol, after 
evaporating a volume of 1ml to dryness, showed maximal 
recoveries of 80% when using an added antioxidant (BHT, 
0.01%). 
In summary, it appears that plasma retinol can be 
isolated from plasma, purified by HPLC, partitioned into 
hexane, dried (MgSO^), and concentrated with maximal 
yields of 60-80%. It also appears that derivatizing this 
concentrated retinol with TMSDEA and subsequent manipulation 
and analysis by GLC coupled with a flame ionization detector 
shows yields of 40-50%. 
In the separation of vitamin A by GLC, short packed 
(3ft) and capillary columns (12-15meter) gave the best 
recoveries. Oven temperatures of 200*C were generally 
required for elution of TMS-retinol from both packed (3% 
OV-101) and capillary columns. Lower temperatures, although 
theoretically preferable, gave retention times of such a 
long duration that TMS-retinol was destroyed before eluclon. 
Packed columns used isothermally at 230*C gave the best 
results while a temperature range from 200-230®C, with 
Increments of 4-10*C/min from 200°C, were normally employed 
for capillary columns. 
The allowable volumes of solvent injected on a GLC 
column are considerably less than those found with HPLC. 
For analytical GLC, Injection volumes are generally In the 
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range of l-2ul, with a lOul maximum. Capillary columns 
accommodate even less solvent and, depending on the injec­
tion mode, samples oE less than lui are generally employed. 
The problem of a limited sample volume was circumvented 
by employing a dry-column injector, which is diagrammed in 
Figure 33. By using this injector, a sample of 20ul may be 
applied to the tip of a glass rod over which a vented stream 
of carrier gas passes. When the solvent has evaporated, the 
vent is closed, carrier gas again flows through the GLC 
column, and the glass rod tip is inserted into the heated 
injector where the applied sample is vaporized and carried 
into the column. This injector allowed samples of 
manageable size to be analyzed, in contrast to the 
difficulty in concentrating and injecting samples of l-2ul. 
This injector may be coupled directly to either packed or 
capillary columns. 
Prior to the use of this injector, a modified splitless 
injection technique was employed with capillary columns. In 
normal splitless injections the oven temperature is lowered 
10-20®C below the boiling point of the carrier solvent. An 
injected sample is vaporized in the injector port but 
recondenses in the first few centimeters of the column. The 
oven temperature is then raised to allow sample solvent and 
solute to elute. The recovery of retlnol derivatives by 
this procedure was poor, probably because of destruction of 
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Figure 33. Diagram of a dry-column Injector (Ray Allen, 
Denver CO) 
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the adsorbed compound on the hot glass surface. A modified 
splltless injection allows all injected material to pass 
into the capillary column at the normal operating 
temperature of the column. This procedure gave recoveries 
similar to those with the dry-column Injector. The latter 
was preferred, however, because larger amounts of sample 
could be used. 
Capillary columns positioned such that column effluent 
passed directly into the mass spectrometer ionizer gave 
responses greater than an equivalent amount Injected into a 
packed column and passed through a jet separator. Wide 
variations In response were noted with this procedure, 
however, depending on the exact position of the capillary 
column outlet with respect to the ionizer. 
The fragmentation of vitamin A In a mass spectrometer 
was dependent upon the type of mass spectrometer used. A 
Flnnegan 4000 MS system gave m/z 268 as the largest high 
molecular weight species. This fragment Is most likely 
anhydroretlnol, the dehydration product of retlnol. The 
ExtraNuclear mass spectrometer gave m/z 255 
(M -CH^-OSlCMe)^) as the largest high molecular 
weight fragment. Injecting known quantities of standard 
TMS-retlnol showed linearity down to 20ng when plotting the 
area of m/z 255 (ExtraNuclear) or m/z 268 (Flnnegan) against 
the quantity of TMS-retlnol Injected (Figure 26). These 
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masses were monlcored either by scanning repeclcively from 
240-380amu and plotting Individual masses, or by 
simultaneous ion monitoring (SIN) where individual masses 
are monitored sequentially. The SIM mode gave maximum 
sensitivity and was used in obtaining the lower detection 
limit of 20ng. Chemical ionization with methane or 
isobutane failed to Increase this sensitivity. 
Standard solutions of TMS-retinol and tetradeuterated 
TMS-retinol containing 66ng total retinoid could be measured 
with a relative standard error of 3% at a ratio of 1/1. 
This error Increased as the ratio departed from unity in 
either direction (Table II). These values were calculated 
by measuring area ratios of m/z 255 and m/z 259 in the SIM 
mode. 
Thus, the potential exists for analyzing the ratio of 
deuterated to non-deuterated retinol in plasma by GLC-MS. 
Indeed others (18, 93) have reported the non-deuterated/-
deuterated ratio of plasma retinol after the oral 
2 
administration of 11,12- H2-retinyl acetate in a limited 
number of rats, sheep, cattle and one human. No 
chromatographic conditions or experimental procedures were 
described, however. Nonetheless, they concluded that a 
"semi-quantitative determination of the human vitamin A body 
pool might be possible" (18). No further details of this 
group's procedure have been published. 
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To Improve Che sensiclvicy of this assay, the recovery 
at each step in the procedure, from the extraction of 
retlnol from plasma to the analysis by GC/MS, was 
determined. The yield at each step Is summarized In Table 
VI. 
Table VI. Measured yields at Individual steps In the 
analysis of plasma retlnol 
STEP-WISE YIELDS OF VITAMIN A 
STEP Z YIELD 
Plasma Extraction 90-100 
Partitioning and Drying (MgSO,) >95 
Concentration 50-80 
Derlvatlzatlon >95 
Derivative Recovery 40-50 
Overall Yield 16-36 
The overall range of yields of plasma retlnol to the 
recovery of TMS-retlnol, I.e., Immediately prior to GLC-MS 
analysis. Is 16-36%. As shown In Figure 26, the GLC-MS 
analysis showed linearity to 20ng of TMS-retlnol Injected. 
Since the sample will be a mixture of deuterated and 
non-deuterated material, the minor component should be 
Introduced at levels of 20ng or greater. With a typical 
ratio of 1/5, I20ng of material would be required for 
Introduction Into the GLC-MS. Thus, 750ng of retlnol from 
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plasma, based on a maximum overall yield oC 16%, would 
initially be needed. Ac a plasma level o£ 30ug/dl, chis 
amounc would be present in 2.5ml of plasma. Unfortunately, 
plasma samples of Chis size, or even larger, yielded no 
detectable TMS-retinol when analyzed by CLC-MS. Only plasma 
extracts containing enough retinol (l0-20ug) to completely 
overload the GLC-column were measurable by GLC-MS. Plasma 
samples that provided this amount of retinol (30-60ml) 
required additional purification steps in order to reduce 
the large amount of lipid co-extracted with retinol by 
hexane. Furthermore, plasma samples of this size clearly 
are not practical for survey purposes. 
One possible reason for this failure is that the 
maximum yield determined for each Isolated step may not be 
achieved when the whole procedure is employed. Another Is 
that plasma may contain factors that enhance the destruction 
of retinol, particularly during GLC-MS analysis. In this 
regard, the sensitivity of GLC-MS analysis was determined 
with pure TMS-retlnol, not with a plasma extract. 
An alternate approach to this analysis would be the 
direct coupling of HPLC effluent to a mass spectrometer. 
Because flow rates of 0.5-5ml/mln In a liquid chromatograph 
(LC) are equivalent to l00-3000ml/mln for common solvents 
after vaporization, special Interfaces must be developed to 
accommodate this conversion (142). Two of the most 
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successful appear do be the moving belt Interface and the 
thermospray Interface (143,144). A moving belt Interface 
employs a continuously moving belt to which the LC effluent 
Is applied and from which the solvent Is evaporated. The 
belt moves through several vacuum locks to the Ion source 
(143). The solute Is then either thermally desorbed and 
then Ionized or Is directly bombarded by an energetic beam 
to produce secondary Ions (145). The thermospray system 
employs a heated metal capillary through which the LC eluate 
passes. This eluate Is vaporized Into a stream of vapor and 
aerosol. The solute concentrates In the aerosol (droplet#). 
The vapor, which contains 95% of the solvent, Is then 
removed by a Jet separator. The aerosol passes to the 
Ionizer, where the solute Is Ionized by proton transfer from 
residual solvent to give (M+H)^ as the major molecular 
species (146). Under optimal conditions little 
fragmentation occurs. Both of these systems may prove 
effective for direct analysis of plasma retlnol by LC-MS. 
Some of the newer Ionization techniques, such as fast 
atom bombardment (FAB) and resonance-enhanced multlphoton 
ionization (REMI) (140,147) may also be employed to improve 
the sensitivity of MS analysis. Both of these ionization 
techniques are effective in producing molecular ions of heat 
labile material that cannot be introduced into an ionizer 
via GLC. In these ionization techniques, the sample is 
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applied Co a metal surface, from which it is desorbed and 
ionized either by fast moving Xe atoms (FAB) or by 
excitation and heat from a tunable laser (REMI). The 
combination of applying the LC aerosol from a thermospray 
unit onto a moving belt LC-MS interface, followed by 
ionizing the sample from the belt with a laser desorptlon 
Ionizer, has also been recently reported (148). 
Another recent advance is mass spectrometry coupled 
mass spectrometry (MS/MS). In these systems a complex 
mixture can be Introduced Into the first Ionizer and a 
single molecular ion or fragment selected to pass to the 
second ionizer and mass filter for further analysis (149). 
A single MS requires a pure sample for reasonable signal to 
noise ratios to be achieved. In contrast, MS/MS allows high 
sensitivity to be achieved from complex mixtures. This 
system may prove to be beneficial in the analysis of crude 
extracts of plasma retinol. 
Vitamin A Is catalytically hydrogenated in quite good 
yield to the stable compound, perhydro-vitamin A (150). 
Upon analysis by GLC, perhydro-vitamin A elutes as a single 
peak with a sensitivity of approximately l.6ug (151). The 
sensitivity of detection of perhydro-vltamln A during 
subsequent analysis by GLC-MS will certainly be much greater 
than that of retinol or Its derivatives. The stability of 
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Che deuCerlum label in deuceraced vicamin A during catalytic 
hydrogénation is unknown, however. 
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CONCLUSION 
Several deuCeraCed analogues of vitamin A have been 
2 
synthesized by two methods. The aldehyde, 20,20,20- Hg 
retinaldehyde, was prepared by the approach of Tanis £t 
al» (Tetrahedron Lett. 1978, 10, 869-872) based on a 
modification of Wittig's directed aldol condensation. Four 
more deuterated analogues of vitamin A were synthesized 
based on the use of a Wittig-Horner reaction and deuterium 
exchange for the Incorporation of deuterium. These 
analogues included 20,20,20-^H2 retinol, 14,20,20,20-^H^ 
retlnol, 12,l4,20,20,20-^H5-retlnol and 10,19,19,19-^H^ 
retinol. The last compound contains deuterium with 99% 
deuterium in the cited positions. The deuterated analogues 
were characterized by NMR, UV, HPLC, and mass spectral 
analysis. 
These deuterated analogues were synthesized for use in 
an isotope dilution assay for vitamin A in humans. The 
majority of the technical details needed for such an 
analysis were worked out, including the extraction, 
quantitation, purification and recovery of the vitamin from 
plasma. The quantitative mass spectral measurement of the 
ratio of deuterated to nondeuterated labeled vitamin A has 
been refined to levels of 50-100ng of standard vitamin A 
derivatives. Introduction of the sample into the ionization 
130 
source was via gas chromatography. Conditions for efficient 
chromatography were necessarily worked out, Including the 
columns, packings and temperature programs which gave a 
maximum response. Derlvatlzatlon methodology was also 
examined. Including the selection of reagents and conditions 
that give maximum yields of TMS-retlnol in the 0.5-2ug 
range. 
Analysis of each step in the proposed method reveals a 
yield of 16% from plasma. Because of the isomerlzation of 
vitamin A and losses during GC/MS analysis, however, the 
method could not be effectively applied to small (1ml) 
plasma samples. 
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